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Abstract
The pancreas is a glandular organ composed of endocrine and exocrine compartments.
Integrins are cell adhesion molecules that connect cells to the extracellular matrix (ECM).
Integrins modulate a variety of cellular effects, yet their mechanism of action in the
developed pancreas is not well understood. Fibrin is a provisional ECM protein that
contains ligands for integrin receptors. Fibrin is capable of supporting islet health, but it is
unclear how fibrin exerts its effects. The objective of this thesis is to understand the role of
integrin receptors on in vivo pancreatic cell function, survival, and proliferation. In
addition, this thesis investigates how fibrin promotes pancreatic cell maturation, function,
and survival in culture. Pancreatic tissues from transgenic adult mice lacking β1 integrin
were harvested at 4 and 7 weeks post-induction. The rat insulinoma cell line, INS-1, and
human fetal-islet epithelial cells were cultured on tissue culture polystyrene plates or with
fibrin in two or three dimensions for up to 4 weeks, then collected for analyses.
β1 integrin knockout mice demonstrated significant glucose intolerance and reduced
glucose-stimulated insulin secretion (GSIS). β1 integrin knockout mice also had reduced
beta cell expression of Pdx-1 and Nkx6.1, as well as reduced acinar cell expression of
amylase, lipase and Reg-II. Alternatively, to investigate the effects of supplementing
pancreatic cells with ECM in culture, INS-1 cells and human fetal islet-epithelial clusters
were cultured with fibrin. Culturing these cells with fibrin led to significantly increased
integrin αvβ3 expression. INS-1 cells cultured with fibrin had significantly increased GSIS
and significantly reduced caspase-3 cleavage, which was reversed by antibody blockade of
integrin αvβ3. Human fetal islet-epithelial cells cultured with fibrin had increased PDX-1
expression, which was mediated, in part, by the mTOR/p70s6k pathway. Transplantation of
fibrin-mixed human fetal-islet epithelial cells led to maintained differentiation and
improved graft vascularization. Integrins are essential for maintaining glucose homeostasis
and acinar cell function. Furthermore, culturing pancreatic cells with fibrin leads to
increased integrin expression and improved cell maturation, function, survival and
proliferation. Understanding how integrins modulate the pancreas and associated islet cells
will lead to more effective protocols for the culture of isolated islets.
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1

General introduction1

Parts of this work have been published and submitted in the following manuscripts:


Riopel M, Trinder M, Wang R. Fibrin, a scaffold material for islet transplantation and
pancreatic endocrine tissue engineering. Submitted to Tissue Engineering Part B (MS# TEB2014-0188)



Riopel M, Wang R. Collagen matrix support of pancreatic islet survival and function. Front
Biosci 2014;19:77-90



Riopel M, Wang R. Stem cells: a solution for cell replacement therapies in the treatment of
diabetes? In Your Lab: Stem Cell Research Edition. CEDARLANE 2012;20-26
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1.1 Significance of this PhD thesis
Cell-based therapies for diabetes are currently the most promising treatment modality
to render diabetics insulin-independent. Universal availability of these techniques are
limited by a comprehensive understanding of islets. Integrins, a group of cell adhesion
molecules, are critical for integrating the extracellular environment with interior
cellular processes. However, the mechanisms behind these processes in the pancreas
are not completely understood. My studies are significant because I demonstrate the
necessity of cell-extracellular matrix (ECM) interactions in maintaining islet cell health
and provide insight on improving cell-based therapies for diabetes.

1.2 Pancreas anatomy and development
The pancreas is a glandular organ that regulates blood glucose as well as aids in food
digestion. It lies inferior to the stomach, attaches to the duodenum via the pancreatic
duct and is vascularized via the superior mesenteric artery and vein. The pancreas itself
consists of exocrine and endocrine tissue, the latter composing only 2-3% of the total
pancreas mass. The exocrine compartment is made up of acinar cells that produce
digestive enzymes and pH neutralizing bicarbonate through an intricate network of
ducts that lead to the duodenum. The endocrine pancreas is composed of scattered cell
clusters known as the Islets of Langerhans, or more conventionally, islets. Islets are
made up of cells that secrete insulin (beta cells), glucagon (alpha cells), somatostatin
(delta cells), pancreatic polypeptide (PP cells) and ghrelin (epsilon cells). In human
islets, beta and alpha cells make up most of the islet (54% and 36%, respectively), with
a few delta, epsilon and PP cells [1]. Meanwhile, mouse islets are primarily made up of
beta cells (~87%), where alpha cells (7%) make up the periphery of the islet, and a few
delta, epsilon and PP cells [1]. The role of beta cells is to secrete insulin when blood
glucose becomes too high. Subsequently, this insulin will stimulate insulin receptors on
hepatocytes, adipocytes and myocytes. Stimulation of the insulin receptor allows
glucose uptake and promotes glycogen or fatty acid synthesis. Conversely, alpha cells
secrete glucagon in response to low blood glucose, which will stimulate the liver to
produce glucose.
Development of the pancreas is very complex and requires well-timed expression of
transcription factors and signaling pathways. The pancreas is derived from the
2

endoderm germline during development. It begins budding at embryonic day 8.5 in the
mouse [2] or gestational day 25 in humans [3]. A transcription factor essential to the
development of definitive endoderm is the Sry-related HMG box 17 protein (Sox17)
[4]. Two parts of this definitive endoderm evaginate as primitive pancreatic buds, and
express the transcription factors pancreatic duodenal homeobox 1 (Pdx1) and pancreas
transcription factor 1a (Ptf1a) [5], which are essential for pancreatic development.
Distinct signaling pathways dictate the specific expression and repression of
transcription factors, which induce transient expression of neurogenin3 (Ngn3) and
initiate endocrine cell differentiation [6]. Microarray analysis of Ngn3 knockout mice
shows that Ngn3 regulates a large subset of genes required for progression of progenitor
cells into endocrine cells [7]. Neurogenic differentiation 1 and islet-1 are downstream
of Ngn3 and have been explicitly shown to be essential for endocrine lineage
determination [8, 9]. These endocrine precursor cells then split into separate
differentiated endocrine lineages; alpha, beta, delta, epsilon and PP cells, and begin to
organize into islets by embryonic day 16 (for a full review on pancreatic development
see [3, 10]). A set of transcription factors including Pdx1, Nk2 homeobox 2 and Nk6
homeobox 1 (Nkx6.1), Paired box gene 4 and 6, and v-maf avian musculoaponeurotic
fibrosarcoma homolog A (MafA) are required not only for beta cell development, but
also for beta cell maturation and function (reviewed in [11]). If there is a defect during
pancreatic development or the adult pancreas is unable to regulate blood glucose
sufficiently, Diabetes Mellitus (DM) occurs.

1.3 Diabetes Mellitus and treatment options
Endocrine cells make up only 2-3% of cells of the total pancreas mass. This population
plays a critical role in regulating glucose homeostasis. Importantly, impaired glucose
homeostasis is associated with DM; a condition of absolute or relative insulin
deficiency. Type 1 DM refers to the autoimmune condition whereby host T cells attack
beta cells of the pancreas, which results in a state where little to no insulin is produced.
Type 2 DM has a multi-factorial pathogenesis, whereby initial compensatory insulin
production/secretion is insufficient to reduce blood glucose due to peripheral insulin
resistance, reduced beta cell mass, and increased body weight. In both conditions, the
eventual treatment regimen is daily exogenous insulin injections aimed to maintain
blood glucose levels normalized to that of unaffected individuals. This regimen has
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significantly lowered the mortality and morbidity rates of DM. However, it has been
suggested that the blood glucose variability under exogenous insulin treatment may
contribute to long-term complications in diabetic patients such as cardiomyopathies,
neuropathies or retinopathies [12, 13]. Therefore, it is imperative that researchers
discover a curative therapy that leads to physiologic glycemic control, preventing the
need for exogenous insulin and reducing long-term complications.
One proposed DM cure is islet transplantation, a cell-based therapy that removes islets
from a donor pancreas and transplants them into a diabetic individual. Pioneered at the
University of Alberta, the Edmonton protocol for islet transplantation uses a
glucocorticoid-free immunosuppression regimen as islets are transplanted into type 1
DM patients [14]. Patients are initially insulin-independent after transplantation, but
most revert back to insulin injections within 5 years to maintain glycemia due to graft
failure [15]. This graft failure is associated with increased islet cell death and loss of
islet cell function. As such, islet transplantation techniques need to be improved so that
patients can be insulin-independent for their entire lifetimes. One limitation in
mastering these techniques is the unavailability of human islets [16]. Therefore,
methods that can increase the number of islets (specifically beta cells) and improve the
survival and function of existing islets will be critical for the success of islet
transplantation. However, ex vivo islet mass expansion has been a difficult task, since
senescence and loss of islet integrity and insulin expression occur after extended culture
[17]. Moreover, the islet micro-environment plays an important role in maintaining islet
health and the mechanisms behind cell-ECM interactions are largely unknown [18]. In
particular, integrins are the major cell receptor type that integrates signals from the
ECM to the interior of the cell.

1.4 Integrin receptors
Integrins are a class of cell and extracellular matrix (ECM) binding proteins that
integrate the exterior environment to the inside of the cell. Twenty-four combinations
of α and β integrin subunits have been discovered, each with a unique range of affinity
to different ligands (Figure 1-1) [19]. Integrins have been implicated in a large variety
of cellular processes in almost all cell types [20]. They can be categorized based on
their ligand of preference. For example, α1, α2, α10, or α11 associate with β1 to bind

4

Figure 1-1 Mammalian integrin receptors and their preferential binding partners.
Integrin β1 is the most promiscuous receptor, associating with α1, α2, α3, α4, α5, α6,
α7, α8, α9, α10 and α11 to bind with many different ligands. β2 integrin primarily binds
to cell surface receptors and associates with αL, αM, αX, αD. The same is true for αEβ7.
Integrin αv pairs with β3, β5, β6 and β8 to bind to Arg-Gly-Asp domains, while β4
integrin binds to laminins with α6 integrin [19-22].

5

to collagen motifs [21]. Meanwhile, αv associates with β3, β5, β6 or β8 to preferentially
bind to fibronectin type proteins that contain Arg-Gly-Asp (RDG) domains in their
structure (Figure 1-1) [22]. It should be noted, however, that integrins are not restricted
to binding only one ligand and have low affinity to many ligands [22]. Before integrins
can be bound by ligands, integrins must be activated to a high-affinity conformation by
a process termed inside-out signaling [23]. Inside-out signaling is orchestrated by
proteins such as talin [24, 25] and those of the kindlin family [26, 27], which bind to
the intracellular cytoplasmic tails of integrins. Once integrins are in this open, highaffinity state, binding of ligands to integrin receptors leads to a cascade of events,
collectively known as outside-in signaling. The clustering of ligand-bound receptors
into focal complexes or adhesions causes significant downstream effects including
recruitment and activation of second messengers and signaling pathways [28]. Focal
adhesion kinase (FAK) is an important protein that interact with integrin-binding
proteins to mediate intracellular signaling pathways such as mammalian target of
rapamycin (mTOR), v-akt murine thymoma viral oncogene (AKT) and extracellular
signal-regulated kinase 1/2 (ERK1/2) [29-31]. Integrin-linked kinase (ILK) is another
key protein recruited to link integrins to the cytoskeleton and modulate cell migration
[32]. Knockout studies indicate that ILK plays a role in apoptosis [33, 34] and
proliferation via AKT and p27 [35, 36]. Many other proteins are involved in outside-in
signaling that mediate cellular effects, but it is outside the scope of this thesis to discuss
them.

1.4.1

Integrin receptors and signaling pathways in the pancreas

Despite being ubiquitous, the expression of integrins in each organ and cell type varies
tremendously. Wang and colleagues demonstrated that adult human islets express
integrins α3, α5, αv and β1 [37]. Furthermore, endocrine cells of the developing human
pancreas commonly express integrins α3, α5, and α6β1 [38]. Integrins αvβ3 and αvβ5
are also expressed in early human pancreatic progenitors and play a major role in
adhesion and migration [39]. In the rodent pancreas, the integrin receptors α3, α5, and
α6β1 are localized to duct and islet cells [40]. Meanwhile, another report demonstrated
expression of integrins α6 and α3 in acinar cells, α6β4 in the duct, α6β1 in acinar and
ductal cells, and α3β1 in all pancreatic cells [41]. Indeed, the most promiscuous and
well-studied integrin is β1. In human fetal pancreatic cells and adult rat islets, β1
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integrin is critical for the maintenance of cell adhesion, survival and insulin expression
[38, 40]. In the developing mouse pancreas, β1 integrin regulates beta cell expansion
[42]; whereas in the developed mouse pancreas, it is critical for maintaining glucose
homeostasis, beta cell proliferation and survival [43; Chapter 2], as well as exocrine
tissue architecture and function [44, 45; Chapter 3]. In fact, when β1 integrin is ablated
in mouse beta cells, there is a significant reduction in the number of beta cells and
dysregulation in the expression of genes associated with cell cycle progression [42]. In
addition, integrins α1, α2, α3, α4, α5, α6, αv, β1, β3, and β4 have abnormal expression
in pancreatic cancer (reviewed in [46]). β1 integrin has also been shown to play an
important role in the invasiveness of different pancreatic carcinoma cell lines [47].
Taken together, these studies demonstrate that the integrins, especially β1 integrin, play
a critical role in maintaining pancreatic endocrine and exocrine health.
It was previously mentioned that integrin receptor activation mediates intracellular
signaling pathways in order to affect cellular processes. One of the first molecules to
be activated after integrin stimulation is FAK. In beta cells, loss of FAK leads to
decreased beta cell survival and proliferation, along with reduced activation of AKT
and ERK1/2 [48]. Both AKT and ERK1/2 have important roles in regulating beta cell
function, proliferation and survival. In general, AKT is critical for the regulation of cell
growth, survival, and proliferation (reviewed in [49]). In beta cells, activation of AKT
leads to cell cycle progression by regulating cyclin dependent kinase 4, cyclin D1,
cyclin D2 and p21 [50]. Increasing active AKT during development significantly
increases beta cell replication and beta cell mass [51]. Similar to AKT, ERK1/2
activation mediates cell proliferation and survival in multiple cells types [52]. However,
phosphorylation of ERK1/2 in beta cells is sufficient to stimulate insulin expression
[53]. In vitro, ERK1/2 activation leads to phosphorylation of Pdx-1 and MafA to
promote beta cell function [54]. In this manner, ERK1/2 plays multiple roles in beta
cells, including promoting cell survival, proliferation and function. Meanwhile, AKT
activation is important for beta cell survival and proliferation.
Another intracellular signaling pathway important in the pancreas is the mTOR
pathway. Nutrient sensing has been described as one of the important roles of mTOR
(reviewed in [55]). In beta cells, however, two roles of mTOR have been described.
Firstly, mTOR pathway stimulation promotes beta cell growth and proliferation [56].

7

Alternatively, chronic activation of the mTOR pathway activity (by high glucose) leads
to inhibition of AKT, and eventually beta cell apoptosis [57]. Thus, an important
balance of mTOR stimulation is required to maintain proper beta cell survival and
growth. In order for integrins to activate any of these intracellular signaling pathways,
ligand stimulation is required. The primary ligands of integrin receptors are the proteins
of the ECM.

1.5 The pancreatic extracellular matrix
ECM proteins present in the pancreas include collagen I, collagen IV, fibronectin, and
laminin [58]. Many of these ECM proteins are components of the basement membrane,
which is necessary for the maintenance of islet architecture and acinar cell clusters. The
basement membrane acts as a scaffold for cell attachment and modulates endocrine cell
survival, insulin secretion, proliferation, differentiation, and migration (reviewed in
[58]). However, over production of ECM adversely affects the exocrine pancreas,
potentially causing fibrosis, inflammation, as well as cancer (reviewed in [59]).
Therefore, it appears that an optimal amount of ECM protein is essential for pancreas
survival and function. Two prominently expressed ECM proteins in the pancreas are
collagen I and collagen IV.

1.5.1

Collagen I and IV

In the native rat and human pancreas, collagen I is present in perivascular islet
capillaries. However, the human pancreas also contains collagen I immunoreactivity in
and around islets [60]. Therefore, numerous studies have investigated whether in vitro
replacement of collagen I could maintain islet differentiation, proliferation, survival,
and function [61-73]. In particular, culturing isolated rat islets in a collagen I matrix led
to a significant reduction in islet cell death after 5 days [61] and improved glucosestimulated insulin secretion (GSIS) after 11 days [62]. Using the rat insulinoma cell
line, INS-1, our research group has found that INS-1 cells exposed to collagens I or IV
demonstrated significant increases in cell adhesion, spreading, and proliferation when
compared to cells cultured on either fibronectin, laminin, or tissue-culture polystyrene
[63]. Perturbation of α3β1 integrin interactions with collagen I and IV led to
significantly decreased FAK, ERK1/2, and Akt phosphorylation, and significantly
increased cleaved caspase-3 levels. This indicates that binding between collagen I and
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IV to α3β1 integrin is essential to support the survival of INS-1 cells, human fetal
pancreas, and human adult islets [63, 64]. Analysis of canine islets cultured on collagen
I showed a significant improvement in adhesion, GSIS, and insulin content, all while
significantly reducing islet cell death when compared to controls [65]. Likewise, human
adult islets cultured on a collagen I matrix exhibited significantly improved insulin
response to acute glucose challenge after 3 days and were viable for longer than 8 weeks
[66]. Meanwhile, studies in human fetal pancreatic islet cells demonstrated that β1
integrin blockade resulted in significantly decreased expression of essential islet genes
(insulin, glucagon and PDX-1), along with down-regulation of the FAK/mitogenactivated protein kinase (MAPK)/ERK signaling cascade when cells were plated on
collagen I gels [67]. Islet survival, however, was significantly increased when isolated
islets were cultured on a combination of collagen IV, laminin, and fibronectin when
compared to just collagen I alone [68]. Furthermore, adding a combination of soluble
laminin or fibronectin to the culture media of islets cultured on collagen I prevented
islet-epithelial transformation [69]. Culturing neonatal islets on a collagen I gel led to
significantly increased cell proliferation and expansion of c-Kit-expressing cells, which
was maintained for up to 8 weeks [70]. Past work has also shown that collagen I
supports differentiation and maturation of pancreatic precursor cells into beta cells
when cultured in 3D polyethylene glycol hydrogels [71]. The use of a collagen I-based
3D entrapment method improved adult islet morphology, viability, and function with
no defects in oxygen consumption when compared to controls [72]. Collagen I gels
supplemented with other ECM proteins also supported long-term human islet culture
demonstrating similar insulin stimulation indexes to freshly isolated islets [73]. In
summary, these results suggest that collagen I plays a role in regulating islet cell
proliferation, function, and survival.
Another collagen that has an essential role in the basement membrane surrounding islets
is collagen IV [74]. Many studies have investigated the importance of collagen IV in
vivo, and as a supportive gel in vitro. Injecting streptozotocin (STZ) into neonatal
Wistar rats had a significant impact on glucose homeostasis, and after recovery,
collagen IV expression did not recover to normal, suggesting that collagen IV may be
required to facilitate beta cell growth and function [75]. Collagen IV is also crucial for
beta cell motility and insulin secretion via α1β1 integrin [76]. Likewise, collagen IV
improved adult beta cell insulin secretion in an ERK-dependent manner [77], which
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likely occurs through increased fibroblast growth factor receptor 1 protein expression
[78]. Culturing islets on collagen IV also prevented apoptosis when compared to
controls [68]. We have demonstrated that collagen IV improves human islet and INS-1
cell adhesion, spreading, survival, and function by interacting with integrin α3β1 [63].
However, another immortalized beta cell line, RIN-5F, showed minimal changes in cell
adhesion and proliferation when cultured on plates coated with either collagen I or IV
compared to controls [79]. Using encapsulation methods, collagen IV was able to
improve GSIS, and demonstrated a synergistic improvement when mixed with laminin
[80]. Three dimensional culture of human adult islets in collagens I and IV led to higher
insulin gene expression compared to fibronectin or laminin [81]. Another 3D culture
system was developed using poly(lactic-co-glycolic acid)-collagen hybrid scaffolds,
which supported RIN-5F cell proliferation, function, and differentiation [82]. These
studies indicate that collagen I and collagen IV are able to improve beta cell function,
proliferation, and survival after short term culture.

1.5.2

Collagen-associated islet transdifferentiation

Despite the observed improvements in islet health associated with collagen culture,
reports show that islets cultured on collagen gels end up losing their insulin secretion
function, express markers of ductal cells (CK-19), and form cystic structures [83, 84].
When isolated adult male Sprague-Dawley islets were cultured in collagen gels
(produced from rat tails) with growth factors, there was a time-dependent decrease in
insulin secretion as well as increased CK-19 expression [85]. These results suggest that
collagen may not be able to maintain the differentiated state of islets, and instead
supports the transdifferentiation of islets to a ductal-cell phenotype. Indeed, a similar
finding was observed when culturing isolated adult human [83] and canine [84] islets
in three-dimensional rat tail collagen gels. Development of these duct-like epithelial
cystic structures is initially associated with a significant increase in islet cyclic
adenosine monophosphate, c-Jun N-terminal kinase (JNK) signaling, and cleaved
caspase-3 levels, with reduced ERK/Akt signaling, giving a net effect of increased
apoptosis. Following ductal-like structure formation, there is a consequent reduction in
JNK signaling and cleaved caspase-3 levels with an increase in ERK/Akt signaling
resulting in duct-like cell proliferation [69, 86]. Interestingly, this transdifferentiation
could be reduced, in a dose-dependent manner, by the addition of transforming growth
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factor β [87]. Another research group cultured human islets in a collagen matrix and
showed a concentration-dependent effect of epidermal growth factor on islet
transdifferentiation via the AKT and ERK signaling pathways [88]. As well, when
collagen I-cultured islet-derived duct-like epithelial cells were treated with the islet
neogenesis-associated protein, they re-differentiated back to islet-like structures,
including all four endocrine cell types [89]. Conversely, culturing human islets with
adhered collagen molecules did not lead to duct cell transdifferentiation, but rather to
maintenance of insulin gene expression [83]. This suggests that the negative effects of
collagen culture on islets can be mediated by the addition of growth factors, but that
collagen culture by itself is limited in its usefulness in promoting islet health. In
contrast, a provisional ECM protein that does not promote islet transdifferentiation
during culture is fibrin.

1.6 Fibrin(ogen) and the pancreas
1.6.1

Fibrin structure and function

Fibrinogen is a soluble 340kDa protein that is 45nm in length [90]. Two D domains
make up the outer part of the molecule that is connected by disulfide bridges to a central
E domain. Each D domain is made up of a polypeptide trimer, named Aα, Bβ, and γ
(Figure 1-2) [91]. Fibrinogen also contains the Arg-Gly-Asp (RGD) amino acid
sequence, which acts as a ligand for a number of integrin receptors [92]. Fibrinogen is
produced in the liver of rodents and humans, and circulates in the blood until activation
by thrombin [93, 94]. The enzymatic activity of thrombin cleaves four fibrinopeptides
from both  and  subunits, which allows the resultant fibrin monomers to
conglomerate

and polymerize

[95].

Fibrin

polymerization occurs because

fibrinopeptide cleavage exposes high affinity binding sites on the α and β chains (EA
and EB), which bind to DA and DB sites located on an adjacent fibrin monomers (Figure
1-2) [91]. This process leads to double stranded fibrin fibrils with staggered 22.5nm
longitudinal repeats that eventually branch via bilateral and equilateral junctions [96,
97]. A bilateral junction occurs when two double-stranded fibrils bind adjacently to
one, while equilateral junctions occur when three fibrin monomers interact together.
Most frequently, the combination of both types of junctions leads to a complex mesh
network [91, 98, 99].
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Figure 1-2 Fibrin structure and formation.
Fibrinogen, made by the liver, circulates in the blood stream until activation of the
coagulation cascade, whereby thrombin eventually cleaves fibrinopeptides from
fibrinogen. The resulting molecule is then able to polymerize and form a fibrin
polymer by allowing binding between the D and E fragments. After exposure to factor
XIIIa, D dimers cross-link fibrin polymer to form a fibrin network mesh. Scanning
electron micrograph shown in bottom left to illustrate complex fibrin mesh network.

12

The native function of fibrin is to form a clot to promote wound healing. As wound
healing occurs, the fibrin clot is slowly degraded. In this way, fibrin is a biodegradable
provisional ECM protein [100]. High blood fibrinogen concentration has been
associated with elevated risk of stroke and myocardial infarction [101]. However,
overexpression of native murine fibrinogen in mice did not increase the risk of
occlusive platelet thrombus formation [102]. But, when human fibrinogen was infused
into mice, vessel occlusion occurred more quickly due to abnormally high fibrin content
in the plasma [103]. These findings suggest that reducing native fibrinogen levels in
humans could reduce the risk of thrombosis.
Clot formation is also affected by fibrin’s structure, which can be modified by
alternative splicing of the γ fibrinogen domain. Additionally, the concentration of
fibrinogen and thrombin, pH, porosity, permeability and other factors have been shown
to influence the conformation of fibrin [104-106]. Factors such as diabetes [107],
smoking [108], and homocysteine concentration [109] also have dramatic effects on
fibrinogen’s activity.

1.6.2

Fibrin and integrin receptors

Two means by which fibrin exerts its effects are by acting as a 3D scaffold emulating
the natural extracellular environment and/or by stimulating receptors on the cell
surface. One receptor that is stimulated by fibrin and has a well-established role in
cancer and angiogenesis is integrin receptors αvβ3 [110, 111]. Interestingly, fibrinogen
domains α, γ, and αEC are able to bind to integrin αvβ3 [112]. Given this, fibrin is able
to mediate various effects on different cells. For instance, endothelial cells cultured in
fibrin gels form lumenal structures, which depend on integrins αvβ3 and αvβ5 [113].
These pseudo-capillaries vary based on the relationship between integrin αvβ3
distribution and the stretch resistance of fibrin [114]. Fibrin-integrin αvβ3 interactions
induce morphological changes of endothelial cells, which includes enlarging the
intracellular space [115]. In wound healing, human fibroblast expression of integrin
αvβ3 promotes is essential for adhesion to fibrin and thus migration [116]. Integrin
αvβ3 also mediates fibrin gel retraction during wound repair [117]. Spreading and
migration of smooth muscle cells into fibrin gels is an important step in wound healing
and integrin α5β1 and αvβ3 are required for this process [118]. Furthermore, the αIIbβ3
integrin receptor, which binds fibrin, plays a role in clot formation [119]. Other cell
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surface receptors that bind to fibrin are vascular endothelial cadherin [120], vascular
endothelial growth factor receptor [121], integrin αMβ2 [122], and others [91]. In these
regards, integrin αvβ3 is a key player involved in mediating the cellular effects of fibrin.
An ECM protein related to fibrin in structure and function is fibronectin.

1.6.3

Contrasting fibrin and fibronectin

Fibronectin is a large glycoprotein with essential structural and functional roles. It is
alternatively spliced such that one isoform circulates as plasma fibronectin, and the
other isoform remains as cellular fibronectin [123]. Structurally, fibronectin contains
domains that are able to mediate binding of other ECM proteins, as well as stimulate
integrin receptors [123]. Like fibrin, fibronectin contains RGD domains that are a
ligand for integrins αvβ3 and α5β1, among others [124]. This interaction causes a
conformational change in the integrin receptor and allows outside-in signaling to occur
[125].
Plasma fibronectin, like fibrin, plays a role in the coagulation cascade during wound
healing. Fibronectin and fibrin can interact during clot formation [126]. In the clot,
plasma fibronectin’s presence increases platelet aggregation and stabilizes the
thrombus [127]. Indeed, mice deficient for plasma fibronectin had significantly larger
infarct size after focal cerebral ischemia and reperfusion [128]. Furthermore, in a model
of murine atherosclerosis, loss of plasma fibronectin reduced the number of
atherosclerotic plaques [129].
After these initial steps in wound healing, fibroblasts deposit cellular fibronectin, which
allows other ECM molecules to adhere and thus regulate a variety of cellular processes
through receptor binding [130]. This differs from fibrin because as wound repair occurs,
fibrin is degraded and lost from the wound site. Deposition of this native fibronectin
matrix architecture increases cell proliferation, compared to a mutant fibronectin that
contained similar binding motifs, but an altered matrix, which inhibited cell cycle
progression [131]. This suggests that the entire fibronectin structure, and not just
specific binding motifs, is required for proper receptor activation. Furthermore, altered
fibronectin matrices induced a reduction in FAK phosphorylation and p53 levels, which
led to apoptosis induction [132]. Fibrin and fibronectin have similar functions, yet, the
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characteristics of fibrin are such that it can easily form a 3D scaffold and will support
long-term islet cell growth, function and angiogenesis.

1.6.4

Fibrin use in islet cell culture and transplantation

Fibrin is a provisional matrix protein that can support islet architecture, improve islet
health and promote islet vascularization [133, Chapter 4]. Most importantly, islets
embedded in 3D fibrin can be expanded in vitro without the loss of beta cell function
that is seen with traditional culture techniques [134]. In fact, when human islets were
cultured in fibrin, proliferation, insulin content, and GSIS increased significantly
compared to controls (Figure 1-3) [134]. These improvements to beta cell function are
believed to be associated with the ability of 3D fibrin to maintain cell-cell contacts and
enable cellular response to growth factors both ex vivo and in vivo [133, Chapter 4;
134].
Improvements in GSIS, proliferation, and survival were observed when beta cells were
cultured in 3D fibrin for up to 4 weeks [133, Chapter 4]. Enhancement of fibrin-cultured
beta cell insulin secretion can also be achieved by co-culture with human umbilical vein
endothelial cells [135]. The aforementioned study also showed that the distance
between co-culture cell populations was critical for promoting beta cell functionality
[135]. Fibrin also has a protective effect against apoptotic stimuli, which was
demonstrated by subjecting fibrin-cultured young porcine islets to hydrogen peroxide
treatment [136].
Binding of extracellular matrix proteins, such as fibrin, to integrin receptors is critical
for the maintenance of islet function, differentiation, and survival in vitro and in vivo
[42, 66, 137, 138]. Our previous study demonstrated that mice with a deficiency in β1
integrin had significantly reduced beta cell mass, proliferation, and Pdx-1 and Nkx6.1
expression, as well as reduced signaling through the FAK/MAPK/ERK pathway [42,
Chapter 2]. Culture of beta cells within 2D or 3D fibrin scaffolds showed islet-like
cluster formation with significantly increased glucose-stimulated insulin secretion and
cell proliferation, as well as decreased cell apoptosis for up to 4 weeks [133, Chapter
4]. Fibrin improves beta cell function and survival by increasing integrin v3 protein
levels and increasing the phosphorylation of FAK, Erk1/2 and Akt [133, Chapter 4].
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Taken together, fibrin binds to integrin receptors, promotes and maintains islet cluster
formation, and improves islet health.
Besides binding to integrin receptors, fibrin may promote in vivo islet health by
increasing blood flow to islets via angiogenesis. Embedding islets in 3D fibrin is
associated with significant increases in vessel cord branching from islets [139, 140].
Fibrin scaffolds may promote more effective angiogenesis by inducing the endothelial
cells and endothelial progenitor cells that reside within islets to proliferate and/or
differentiate [140]. Alternatively, the vessel changes may be in response to hypoxia
generated from embedding islets in fibrin gels, which was demonstrated after overnight
culture of human islets in 3D fibrin [141]. Fibrin-embedded human islets that were
supplemented with an oxygen-diffusing medium acted synergistically to promote
improved islet function and survival in vitro [141]. Therefore, utilization of an oxygendiffusing medium seems to be a simple strategy to reduce hypoxic damage to islets
caused by islet isolation and 3D fibrin scaffolds [141].

1.6.5

Fibrin support of islet cell function and survival in vivo

Fibrin has been used as a carrier for many cell types with great success [142]. With
respect to islet transplantation, fibrin improved islet function and survival, whereby
circulating human c-peptide levels were significantly increased in diabetic mice that
received fibrin-cultured islets as opposed to free floating ones [134]. Indeed, the use of
fibrin reduced the required marginal islet mass by up to 90% in a subcutaneous
xenogeneic porcine islet transplantation model [143]. This finding could be explained
by the observation that grafts of fibrin-embedded islets gave rise to larger islets with
more populated endocrine cells than grafts of free-floating islet controls [134].
Mice that received fibrin-cultured porcine islets had highly vascularized islet structures,
along with improved islet viability compared to controls [143]. It has been
demonstrated that the delay in reforming vessel contacts has a significant impact on
islet transplantation outcomes [144]. Therefore, fibrin’s pro-angiogenic effects may be
a major factor in the observed improvements in vivo. In particular, the transplantation
of islets to regions of poorer vascularization, such as subcutaneous sites, may benefit
considerably from incorporation of pro-angiogenic fibrin in the graft [145].
Incorporation of isolated islets into extracellular matrix scaffolds for culture or
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transplantation have also shown to be protective against intraislet endothelial cell death
or dedifferentiation [90]. One experiment discovered that 8 days after fibrin-enriched
human islets were subcutaneously transplanted into mice, there was a significant
increase in islet vessel density and neovascularization [146]. If fibrin scaffolds can be
further confirmed to provide sufficient vascularization to subcutaneously transplanted
islet grafts, the more invasive and complicated kidney subcapsule or portal
transplantation routes may become extinct [147]. However, before this procedure can
enter clinical trials, future studies still need to decipher the mechanism and importance
of donor intraislet endothelial cell versus host endothelial cell contribution to successful
engraftment following transplantation.
The use of fibrin also overcomes technical difficulties associated wth islet
transplantation by allowing islets to be embedded in a fibrin carrier system that does
not interfere with islet function or impose any short-term harm on surrounding tissues
(Figure 1-3) [148]. Subcutaneous transplantation of fibrin-embedded islets was as
effective as transplantation of free-floating islets under the kidney capsule in diabetic
mice [149]. This study’s results further support the notion that fibrin is an effective
carrier [149]. In addition, fibrin reduces islet fragmentation into lone cells that is often
seen in free-floating transplantation procedures [145]. This observation stresses the
utility of fibrin for islet transplantation because dispersed islets have been shown to
undergo an integrin-mediated form of apoptosis known as anoikis [145]. Concentrating
transplanted islet cells also ensures that these cells can generate a high enough
concentration gradient of VEGF and other growth factors in order to promote effective
graft angiogenesis and thus graft survival [145]. As such, fibrin is a great candidate to
use during islet transplantation to improve transplantation outcomes.

17

Figure 1-3 Strategies for fibrin use during cell-based therapies for diabetes treatment.
Schematic diagram for subcutaneous islet transplantation using fibrin. Isolated islets
could be either cultured for long-term or embedded in 3D fibrin, then subcutaneously
transplanted [134, 148]. A gross image of subcutaneously transplanted fibrin-wrapped
human fetal pancreatic cells is shown. The dash arrow indicates the fibrin graft with
vasculature surrounding it.
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1.7 Rationale for thesis and objectives
The pancreas is enriched by ECM proteins that stimulate integrin receptors to mediate
cellular processes. However, the mechanisms behind the dynamics of integrin-ECM
interactions in the pancreas are not clear. The overall objective of this thesis is to
demonstrate the necessity of integrin receptors and ECM proteins in promoting both in
vivo and in vitro proliferation, survival, function, and maturation of pancreatic cells,
especially beta cells. The overall hypotheses in this thesis are: 1) loss of pancreatic β1
integrin leads to glucose intolerance, with reduced proliferation and increased apoptosis
of pancreatic beta and acinar cells and 2) culturing pancreatic cells with fibrin will
improve beta cell function and survival, and maintain differentiation.
The objective of Chapter 2 is to determine the in vivo role of β1 integrin in the adult
murine endocrine pancreas using a conditional β1 integrin knockout mouse model.
The objective of Chapter 3 is to investigate the in vivo role of β1 integrin on the adult
exocrine pancreas using the same mouse model as Chapter 2.
The objective of Chapter 4 is to analyze the role of fibrin-integrin interactions in support
of beta cell function, proliferation, and survival using INS-1 cells.
The objective of Chapter 5 is to discover the beneficial effects of fibrin-culture on
human fetal islet-epithelial clusters and mechanisms behind these effects.
Taken together, these studies will illustrate the requirement of integrin receptors and
ECM to promote and maintain adult and fetal cell function, survival, proliferation, and
maturation. Results from this work have implications for cell-based therapies for
diabetes treatment, especially islet transplantation, as this procedure breaks the
essential connections between cells and their native ECM environment.
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Chapter 2
Conditional β1 integrin-deficient mice display impaired

2

pancreatic beta cell function2
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This work has been published in the following manuscript:
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2.1 Introduction
Integrin-ECM interactions are well known regulators of beta cell survival and function
[1, 2]. Integrin receptors associate with ECM components, enabling cell–cell and cell–
matrix contacts and influence numerous cellular processes, including differentiation,
proliferation and function [3 - 5]. The most extensively studied integrin in islet biology
is β1. Its association with 12 α subunits [5] involved in the regulation of
morphogenesis [6, 7], differentiation, proliferation [8, 9] and survival [5] has been
well-documented in beta cells. Integrins α3β1 and α6β1 mediate the attachment and
spreading of rat beta cells on collagen I and 804G matrices, respectively, improving
cell survival and insulin secretion [10, 11]. Moreover, our and other studies have
shown that perturbing β1 integrin function in isolated islets from pre- and post-natal
rat and human fetal pancreas caused decreased adhesion on ECM and increased islet
cell apoptosis [1, 2, 12, 13]. Recently we also demonstrated that β1 integrin collagen I
and IV interactions in rat insulinoma cell line, INS-1, is essential for survival,
proliferation and insulin secretion [14], and that β1 integrin activation of the
FAK/MAPK/ERK signalling pathway enables the differentiation and survival of
human fetal islet cells [15].
We have used mice homozygous for a loxP - integrin β1 allele and hemizygous for
tamoxifen-dependent cre recombinase expressed under the control of a collagen type I
promoter, to test whether a conditional knockout of β1 integrin in collagen I-producing
cells would have physiological and functional implications in pancreatic endocrine cells
in vivo. Our results show that male β1 integrin-deficient mice demonstrate significant
alterations in glucose tolerance and beta cell mass by 4 weeks post-tamoxifen injection
(7 weeks of age), along with significantly reduced phospho-FAK/ERK1/2 signals and
increased caspase-3 cleavage in the pancreas.
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2.2 Materials and methods
2.2.1

Conditional β1 integrin-deficient mice

C57BL/6 mice with a tamoxifen inducible cre recombinase controlled by the col1a2
promoter were crossed with floxed β1 integrin mice to generate conditional β1 integrin
knockout mice in collagen I producing cells [16]. The mice used for experiments were
genotyped by polymerase chain reaction (PCR) to detect β1 integrin and Cre as
described previously [16]. The β1 integrin knockout was induced in 3 week old mice
by intraperitoneal (i.p.) tamoxifen injection (4-hydroxytamoxifen; Sigma, St. Louis,
MO, USA) [17]. Deletion of β1 integrin in the pancreas was determined by real-time
reverse transcriptase PCR (qRT-PCR; Appendix 5), western blot (Rabbit anti-β1
integrin, Millipore, Billerica, MA, USA) and immunofluorescence staining (Goat antiβ1 integrin, R&D Systems, Minneapolis, MN, USA; Figure 2-1). Controls include corn
oil-injected Cre+ mice [Cre+ Ctrl] and tamoxifen-injected Cre- mice [Cre- Ctrl]. All
protocols were approved by the Animal User Subcommittee at the University of
Western Ontario, in accordance with the guidelines of the Canadian Council of Animal
Care (Appendix 1).

2.2.2

RNA extraction and real-time RT-PCR

Total RNA was extracted from pancreata of β1 integrin-deficient and control mice at
1 week post-injection using the miRNeasy kit (Qiagen, Germantown, MD, USA). For
each reverse transcription reaction, 2 mg of total RNA from whole pancreatic tissue
were used with oligo(dT) and random primers, as well as Superscript reverse
transcriptase (Invitrogen, Burlington, ON, CAN). Sequences of PCR primers used for
qRT-PCR with expected size of product are listed in Appendix 5. A master mix of
primers, water and SYBR green was made and then added to separate tubes with each
cDNA sample. Real-time RT-PCR analyses were conducted using the CFX manager
software (Bio-Rad Laboratories, Mississauga, ON, Canada) and CFX Connect RealTime System (Bio-Rad Laboratories). Data were normalized to levels of 18S RNA
subunit and relative gene expression was calculated based on the 2ΔΔCT method as
PCR signals from β1 integrin-deficient pancreata relative to control pancreata.
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2.2.3

Immunofluorescence and morphometric analyses

Body weight, intraperitoneal glucose (IPGTT) and insulin (IPITT) tolerance tests were
performed in β1 integrin knockout (β1KO), Cre+ Ctrl and Cre- Ctrl mice at 4 and 7
weeks post-injection [18]. For the IPGTT, glucose [D-(+)-glucose; dextrose; Sigma] a
dosage of 2 mg/g of body weight was administered (i.p.) and blood glucose levels were
examined at 0, 15, 30, 60 and 120 minutes after injection. Area under the curve (AUC)
was used to quantify glucose responsiveness [18, 19]. For the IPITT, normal human
insulin (Humalin, Eli Lilly, Toronto, Ontario, Canada) at 1 U/kg of body weight was
injected [18]. GSIS tests were performed on 7 week post-tamoxifen injected male β1
integrin-deficient mice and age-matched controls. Blood samples were collected before
(0 minutes) and after glucose loading at 5 and 35 minutes [18]. Insulin secretion levels
were assessed by enzyme-linked immunosorbent assay (ELISA).

2.2.4

In vivo metabolic studies and glucose-stimulated insulin
secretion

Pancreatic tissues collected from β1 integrin-deficient, Cre+ and Cre− Ctrl mice at 4
and 7 weeks post-injection were fixed in 4% paraformaldehyde. Pancreatic tissue
sections (4 µm thick) were prepared from the entire length of the pancreas and stained
with haematoxylin and eosin (H&E), Masson’s trichrome (for total collagen
analysis), picrosirius red (for birefringent collagen I staining [20]) or with
appropriate dilutions of primary antibodies, as listed in Appendix 4. Fluorescent
secondary antibodies were obtained from Jackson Immunoresearch Laboratories
(West Grove, PA, USA).
Areas of alpha and beta cells in sections from all groups were traced manually with
a minimum of five pancreata per age group per experimental group. Total alpha and
beta cell mass was determined using previously described methods [21]. The
percentage of Ki67, Pdx-1 and Nkx6.1 labelled in beta cells was determined by
double immunostaining and counting beta cells from at least 12 islets randomly per
pancreatic section (Appendix 4).
To measure islet capillary area, sections were double stained with anti-mouse platelet
endothelial cell adhesion molecule (PECAM-1) antibody and insulin (Appendix 4).
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At least 12 islets per section were selected at random, and islet capillaries were traced
manually. The ratio of islet capillary area to the total islet area was calculated to
determine the proportion of vessels occupying the islet area [22]. A minimum of five
pancreata per age group per experimental group was analysed [18].

2.2.5

Insulin enzyme-linked immunosorbent assay (ELISA)

Pancreatic insulin was extracted in an ethanol – acid solution (165 mM HCl in 75%
ethanol). Plasma and pancreatic insulin content were measured using a mouse
ultrasensitive insulin ELISA kit (ALPCO, Salem, NH, USA) with a sensitivity of 0.15
ng/ml, according to the manufacturer’s instructions. Insulin release and content was
expressed as ng/ml and ng/mg protein, respectively.

2.2.6

Protein extraction and western blot analysis

Protein extraction and western blot analyses were conducted as previously described
[15]. Briefly, protein from β1 integrin-deficient and Cre+ control pancreata was
extracted in Nonidet-P40 lysis buffer. Equal amounts (35 μg) of lysate proteins from
each experimental group was separated by either 5%, 10% or 12% sodium dodecyl
sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to a
nitrocellulose membrane (Bio-Rad Laboratories). Membranes were incubated with
appropriate dilutions of primary antibodies, as listen in Table 2 (see Appendix 4),
followed by the application of appropriate horseradish peroxidase (HRP)-conjugated
secondary antibodies (Santa Cruz Biotechnologies, Santa Cruz, CA, USA). Proteins
were detected using ECL-Plus western blog detection reagents (Perkin Elmer,
Wellesley, MA, USA) and exposed to BioMax MR Film (Kodak, Rochester, NY,
USA), Densitometric quantification of bands at subsaturation levels was performed
using Syngenetool gel analysis software (Syngene, Cambridge, UK) and normalized
to appropriate loading controls. Data are expressed as the relative expression levels of
phosphorylated proteins to total protein levels or protein levels to the loading control
(calnexin) [15].

2.2.7

Statistical analysis

Data are expressed as mean ± standard error of the mean (SE). Statistical significance
was determined using either the unpaired Student’s t -test or one-way analysis of
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Figure 2-1 Decreased β1 integrin expression in the pancreas of knockout mice
(A) qRT – PCR analysis of β1-integrin mRNA (n = 5) and (B) immunofluorescence
staining for β1 integrin in pancreata from 1 week post-injected male β1 integrindeficient and Cre+ control mice. (C) Western blots and quantitative analysis of β1
protein (n = 3) in pancreata from 4 weeks post-injected male β1 integrin-deficient and
Cre+ control mice. Data are expressed as means  SE. ∗p < 0.05, ∗∗p < 0.01 versus
Cre+ control mice. Scale bar = 50 µm. KO, knockout; Ctrl, control
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Supplemental Figure 2-i Effect of β1 integrin deficiency on the pancreas of 4 week
post-injected β1 integrin knockout mice.
Body and pancreas weight of β1 integrin knockout male and female mice with
respective controls. Data are expressed as means  SE (n=5-10). *p<0.05 vs. Cre+and Cre--control mice.
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variance (ANOVA), followed by post hoc least significant differences and Bonferroni
comparison test. Differences were considered statistically significant when p < 0.05.

2.3 Results
2.3.1

Decreased β1 integrin expression observed in the
pancreas of β1 integrin-deficient mice

By 1 week post-tamoxifen treatment, the expression of β1 integrin mRNA in the
pancreas of β1 integrin-deficient mice was significantly reduced by 50%, determined
by qRT – PCR (p < 0.05, Figure 2-1A), and showed decreased β1 integrin staining in
pancreatic exocrine and islet cells (Figure 2-1B). Total β1 integrin protein in the
pancreas was significantly reduced after 4 weeks post-tamoxifen injection (p < 0.01,
Figure 2-1C).

2.3.2

β1 integrin-deficient mice showed a reduction of body and
pancreas weight

The body weight of male β1 integrin-deficient mice displayed significant decreases at
4 and 7 weeks post-tamoxifen injection when compared to Cre+ and Cre− controls (p
< 0.05, Figure 2-2A, upper panel; Supplementary Figure 2-i). However, reduced
weight in female β1 integrin-deficient mice was only observed at 7 weeks posttamoxifen injection when compared to female Cre controls (p < 0.05, Figure 2-2A,
upper panel; Supplementary Figure 2-i). A significant reduction in pancreatic weight
was found in male β1 integrin-deficient mice 7 weeks post-tamoxifen injection when
compared to corresponding controls (p < 0.05, Figure 2-2A, lower panel;
Supplementary Figure 2-i).
It was noted that the pancreas of β1 integrin-deficient mice at 7 weeks post-tamoxifen
injection appeared edematous (Figure 2-2B, upper panel). H&E staining of pancreatic
sections revealed highly fragmented and torn tissue, as well as islets isolated from
surrounding exocrine cells (Figure 2-2B, lower panel). Furthermore, Masson’s
trichrome (Figure 2-2C, upper panel) and picrosirius red (Figure 2-2C, lower panel)
staining revealed a relative reduction in collagen fibres and connective tissue in the
pancreas, especially around pancreatic islets (Figure 2-2C).
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Figure 2-2 Histology and effects of β1 integrin-deficient pancreas
Effect of β1 integrin deficiency on the pancreas of 7 week post-injected β1 integrindeficient mice. (A) Body and pancreas weight of β1 integrin-deficient male and female
mice with respective controls. Data are expressed as mean ± SE (n = 4–8). ∗p < 0.05
versus Cre+ and Cre− control mice. (B) Photographs of the male mouse pancreas
(dotted line) before dissection (top) and haematoxylin and eosin-stained (bottom). (C)
Masson’s trichrome stain shows collagen fibres in blue (top) and picosirius red stain
shows birefringent collagen I in dark red (bottom) of pancreatic sections of male β1
integrin-deficient mice and respective controls. Representative images are shown;
arrows indicate the islets, arrowheads indicate the basement membrane. Scale bars =
100 µm (B); 50 µm (C). KO, knockout; Ctrl, control.

45

51

In vivo β1-integrin knockout affects β cell
function

51

Supplemental Figure 2-ii
Intra-peritoneal glucose tolerance test (IPGTT) in female (A) and male (B) β1 integrin
knockout, Cre+ and Cre- mice at 4 weeks post-injection. Glucose responsiveness of the
corresponding experimental groups is shown as a measurement of the area under the
curve of the IPGTT graphs with units of (mmol/L). Data are expressed as means  SE
(n=6-14). *p < 0.05 vs. Cre+- and Cre--controls. (C) Intra-peritoneal insulin tolerance
test in β1 integrin knockout, Cre+ and Cre- control mice at 4 weeks post-injection
showed no changes in insulin sensitivity in all experimental groups (n=6-14).
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Impaired glucose tolerance and insulin secretion in β1
integrin-deficient male mice

To evaluate the effects of β1 integrin deficiency on glucose metabolism,
glucose/insulin tolerance tests were examined at 4 and 7 weeks post-injection. No
significant changes in IPGTT were observed in female β1 integrin-deficient mice,
despite the comparably higher peak level at 30 minutes to the controls (Figure 2-3A,
Supplementary Figure 2-iiA). However, significantly impaired glucose tolerance was
observed in male β1 integrin-deficient mice at 4 and 7 weeks post-tamoxifen injection
(p < 0.05, Figure 2-3B; Supplementary Figure 2-iiB). A significant increase in blood
glucose levels at 15 (p < 0.05) and 30 (p < 0.05) minutes following intraperitoneal
glucose load was observed in male β1 integrin-deficient mice at 4 (Supplementary
Figure 2-iiB) and 7 (Figure 2-3B) weeks post-injection, along with significantly
increased area under the curve (AUC) of the IPGTT (p < 0.05, Figure 2-3B;
Supplementary Figure 2-iiB). Furthermore, insulin sensitivity, as determine via IPITT,
was unaltered among the experimental groups at 4 and 7 weeks post-injection (Figure
2-3C; Supplementary Figure 2-iiC). Assessment of GSIS showed less insulin secretion
in 7 week post-injected male β1 integrin-deficient mice compared to Cre+ control
littermates (Figure 2-3D).

2.3.4

β1 integrin-deficient mice showed a reduction of beta cell
mass along with reduced pancreatic insulin content

Our results showed that male β1 integrin-deficient mice display diabetic symptoms at
4 weeks post- tamoxifen injection. Therefore, morphometric analyses were performed
to further examine effects of lacking β1 integrin. The number of islets in the pancreas
revealed no difference between the genders or between the β1 integrin-deficient mice
and their controls at 7 weeks post-injection (Figure 2-4A). However, partitioning islets
by size showed a significant increase in small islets (<500 µm2), with decreases in
large (2501 – 10 000 µm2) and extra-large (>10 000 µm2) islets in male β1 integrindeficient mice pancreas when compared to controls at 7 weeks post-injection (Figure
2-4B). No difference in islet size was observed in female β1 integrin-deficient mice.
Morphometric analysis revealed no changes in alpha cell mass between the genders
and among study groups at 4 (Supplementary Figure 2-iiiA) and 7 (Figure 2-4C) weeks
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Figure 2-3 Metabolic studies in β1KO mice and controls
Intraperitoneal glucose tolerance test (IPGTT) in (A) female and (B) male β1 integrin
knockout, Cre+ and Cre− mice at 7 weeks post-injection. Glucose responsiveness of
the corresponding experimental groups is shown as a measurement of the area under
the curve of the IPGTT graphs with units of (mM). Data are expressed as mean ± SE
(n = 5 – 10). ∗p < 0.05 versus Cre+ and Cre− controls. (C) Intraperitoneal insulin
tolerance test in β1 integrin knockout, Cre+ and Cre− control mice at 7 weeks postinjection showed no changes in insulin sensitivity in all experimental groups (n = 3
– 12). (D) Glucose-stimulated insulin secretion of 7 week post-injected male β1
integrin knockout and Cre+ control mice. β1 integrin-deficient mice demonstrate a
reduction in plasma insulin release after glucose loading (n = 3 – 6). KO, knockout;
Ctrl, control.
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Supplemental Figure 2-iii Morphometric analysis of alpha (A) and beta cell (B) mass
in β1 integrin knockout and Cre control mice at 4 weeks post-injection (n=3-6).
Glucagon (C) and insulin (D) positive area over islet area in male β1 integrin knockout
pancreas compared to controls (Cre+/Cre-) at 7 weeks post-injection (n=3-4). (E)
Insulin positive area per pancreatic section area and (F) ratio of alpha to beta cells in
the pancreas of male β1 integrin knockout and control mice at 7 weeks post-injection
(n=3-7). Data are expressed as means  SE. *p < 0.05, **p < 0.01 vs. Cre+- and Cre-controls.
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post-injection. beta cell mass of 4 (Supplementary Figure 2-iiiB) and 7 (Figure 2-4D)
weeks post-tamoxifen injected β1 integrin-deficient male mice showed a significant
reduction when compared to controls (p < 0.05 for 4 weeks, p < 0.001 for 7 weeks,
Figure 2-4D).
To confirm that the reduction in beta cell mass was not only due to the reduction in
pancreatic weight, we examined the ratio of beta cell area to either islet (Supplementary
Figure 2-iiiD) or pancreatic section area (Supplementary Figure 2-iiiE) and found an
absolute reduction of total beta cell area in male β1 integrin-deficient mice (p < 0.05 –
0.01). Islets of 7 week post-injected β1 integrin knockout males had significant beta
cell loss, which resulted in a relative increase in alpha cell area in islets (p < 0.05,
Supplementary Figure 2-iiiC). Furthermore, the ratio of alpha cell area to beta cell area
was increased significantly in β1 integrin knockout males when compared to controls
(p < 0.05, Supplemental Figure 2-iiiF). Although female β1 integrin-deficient mice did
not show a statistically significant glucose metabolic disorder at either 4 or 7 weeks
post-tamoxifen injection, a significant reduction in beta cell mass at 7 weeks posttamoxifen injection was observed when compared to controls (p < 0.05, Figure 2-4D).
Furthermore, pancreatic insulin content was significantly decreased in β1 integrindeficient male (p < 0.01) and female (p < 0.05) mice at 7 weeks post-tamoxifen
injection when compared to controls (Figure 2-4E).

2.3.5

Reduced beta cell proliferation, Pdx-1 and Nkx6.1
expression in β1 integrin-deficient mice

A significant reduction in Ki67+/insulin+-labelled cells was observed in 4 (p < 0.05;
Supplementary Figure 2-ivA) and 7 (p < 0.05; Figure 2-5A) week post-tamoxifen
injected male β1 integrin-deficient mice when compared to controls. Although female
β1 integrin-deficient mice showed lower proliferative capacity than that of the controls,
no statistical significance was observed (Figure 2-5A). Furthermore, we found that
Pdx-1 expression, a transcription factor important in regulating insulin gene
expression, was significantly decreased in beta cells of both male (p < 0.001) and
female (p < 0.05) β1 integrin-deficient mice at 4 and 7 weeks post-tamoxifen injection
when compared to their respective controls (Figure 2-5B; Supplementary Figure 2ivB). Moreover, a significant decrease in Nkx6.1 expression was observed in 7 week
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Figure 2-4 Morphometric analysis of β1KO mice and controls
Morphometric analysis of (A) islet numbers, (B) islet size, (C) alpha cell mass and
(D) beta cell mass in β1 integrin-deficient and Cre control mice at 7 weeks postinjection (n = 4 – 9). (E) Insulin content in the pancreas of β1 integrin-deficient and
Cre controls at 7 weeks post-injection (n = 5). Data are expressed as mean ± SE. ∗p
< 0.05, ∗∗p < 0.01 ∗∗∗ p < 0.001 versus Cre+ and Cre− controls. KO, knockout; Ctrl,
control.
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Supplemental Figure 2-iv Quantitative analysis of Ki67 (A), Pdx-1 (B), Nkx6.1 (C)
expression in beta cells of β1 integrin-deficient and control mice at 4 weeks postinjection. Data are expressed as mean percent of positive cells over insulin+ cells  SE
(n=3-8) *p < 0.05 and **p < 0.01 vs. Cre+- and Cre--controls.
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post-tamoxifen injected male and female β1 integrin-deficient mice when compared to
controls (p < 0.05, Figure 2-5C).

2.3.6

Reduced islet capillary area in male β1 integrin-deficient
mice

To understand whether pancreatic β1 integrin deficiency had an affect on islet
vasculature, a measurement of islet capillary area was performed in both β1 integrindeficient and control mice at 7 weeks post-injection. Double immunofluorescent
staining for PECAM-1 and insulin showed less PECAM-1+ area present in islets of β1
integrin-deficient mice (Figure 2-6A). Male β1 integrin-deficient mice demonstrated
40% less islet capillary area per islet when compared to controls (p < 0.05, Figure 26B), while β1 integrin-deficient females displayed only a slight reduction when
compared to controls (Figure 2-6B).

2.3.7

Reduction of phospho-FAK, phospho-ERK1/2 and cyclin
D1 expression along with increased caspase 3 cleavage in
β1 integrin-deficient male mice

Our previous studies have demonstrated that β1 integrin signals primarily via the FAK
– MAPK – ERK1/2 pathway to regulate proliferation and function in isolated beta cells
[15]. Here, we revealed the in vivo pancreatic β1 integrin signalling cascade and found
a 40% reduction in phospho-FAK (p < 0.05, Figure 2-7A), with a 75% reduction of
phospho-ERK1/2 levels (p < 0.001, Figure 2-7B) in 4 week post-tamoxifen injected
β1 integrin- deficient male mice compared to Cre+ controls. Furthermore, an increase
in cleaved caspase 3 (p < 0.01, Figure 2-7C) and a reduction of cyclin D1 expression
(p < 0.001, Figure 2-7D) was detected in β1 integrin-deficient male mice, while there
was no alteration in phospho-Akt expression in the pancreas (Figure 2-7F). Finally,
western blot analysis showed a 50% reduction in Pdx-1 expression in β1 integrindeficient male pancreas when compared to controls (p < 0.05, Figure 2-7E).

2.4 Discussion
We have shown that β1 integrin in the pancreas is a critical regulator of beta cell
proliferation and function in vivo. Significant reduction of β1 integrin expression in
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Figure 2-5 Transcription factor expression in β1KO and control mice
Quantitative analysis of (A) Ki67, (B) Pdx-1 and (C) Nkx6.1 expression in beta cells of
β1 integrin-deficient and control mice at 7 weeks post-injection. Data are expressed as
mean percentage of positive cells over insulin+ cells ± SE (n = 4–7) ∗p < 0.05 and ***p
< 0.001 versus Cre+ and Cre− controls. KO, knockout; Ctrl, control.
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the pancreas resulted in disrupted pancreatic morphology, including a reduction of
total pancreatic weight and pancreatic collagen matrices. ECM proteins are well
known to be essential for cell – cell interactions and promoting cell survival and
function through integrin receptors [23]. As such, loss of β1 integrin in pancreatic
ECM-producing cells contributed to the observed reduction in pancreas weight and
altered pancreatic function, which may also be associated with the loss of body weight
in β1 integrin-deficient mice. These results were in correlation with a study using mice
with a pancreas-specific knockout of β1 integrin [24]. Furthermore, altered glucose
metabolism in β1 integrin-deficient mice was observed, which was associated with a
50 – 70% reduction in beta cell mass and cell proliferation, along with a significant
decrease in pancreatic insulin content. These results indicate that β1 integrin deficiency
is responsible for the loss of blood glucose control as well as changes in pancreatic
morphology.
It is well established that Pdx-1 and Nkx6.1 expression are integral to normal
development of the pancreas and maintenance of beta cell function [25 – 27]. Reduced
Pdx-1 and Nkx6.1 expression in β1 integrin-deficient mice suggests that not only is β1
integrin required for normal beta cell development and function but that it may be
involved in mediating Pdx-1 and Nkx6.1 protein expression. Mice containing only one
functional allele of Pdx-1 (Pdx-1+/−) demonstrated increased islet cell apoptosis and
reduced beta cell mass [28]. Thus, reduced beta cell mass and insulin content, as well
as glucose intolerance observed in β1 integrin-deficient mice, may also be due to low
levels of Pdx-1 and Nkx6.1 in their pancreatic islets.
Besides transcription factor expression, islet capillary area was also significantly
reduced in β1 integrin-deficient males. Nikolova et al have demonstrated the
requirement for adequate islet endothelial cells for production of basement membrane
components (primarily laminins), which stimulate β1 integrins to promote beta cell
proliferation and insulin gene expression [29]. Also, proper vessel function is
necessary to supply enough blood to islets for ideal glucose sensing and insulin
response [30]. This suggests that β1 integrin loss in islets has an effect on endothelial
cell function, which may further contribute to beta cell dysfunction by restricting blood
flow or impairing the production of basement membrane.
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Figure 2-6 Effect of β1 integrin knockout on islet capillary area
(A) Immunofluorescence staining for PECAM-1 (red) of a 7 week post-injected β1
integrin-deficient and control islet (dotted lines). (B) Morphometric analysis of islet
capillary area at 7 week post-injected β1 knockout and control mice. Data are
expressed as means ± SE (n = 3–6) ∗p < 0.05 versus Cre+ and Cre− controls. KO,
knockout; Ctrl, control. Scale bar = 50 µm.
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In several model systems, β1 integrin has been shown to activate the FAK/MAPK/ERK
cascade to enhance cell survival and function [31, 32]. Hammer et al determined that
804G matrix protects against rat adult beta cell apoptosis through the β1 integrin – FAK
signalling pathway [33], while our previous in vitro studies have demonstrated that β1
integrin signalling through the FAK/MAPK/ERK pathway regulates the differentiation
and survival of human fetal islet cells [15]. To investigate the signalling cascade of β1
integrin in vivo, alterations in phospho-FAK, ERK1/2 and Akt were examined, along
with cyclin D1 expression and caspase 3 cleavage. Significant decreases in phosphoFAK and ERK1/2 were observed, along with reduced cyclin D1 expression and
increased caspase 3 cleavage, but no effect on Akt pathway, indicating that β1 integrin
signals primarily through the FAK/MAPK/ERK cascade in vivo to regulate glucose
metabolism and beta cell survival and function.
Our data indicate that loss of β1 integrin affects pancreatic structure and function in
male, but less in female, mice. The observed differences in the requirement for integrin
β1 in glucose metabolism are consistent with previous results indicating that there are
gender differences in glucose metabolism. Our previous characterization of cKit Wv
mutant mice revealed severe glucose intolerance, reduced beta cell mass and low cell
proliferation rates in insulin+ cells, primarily in male mice [18]. Moreover, oestrogen
administration has been shown to protect mice from beta cell ablation from STZ
administration by preventing beta cell apoptosis [34].
In summary, this study is the first, using a conditional β1 integrin-deficient mouse
model, to demonstrate the physiological and functional effects of β1 integrin
deficiency on the endocrine pancreas in vivo. β1 integrin plays an important role in
maintaining beta cell mass, glucose metabolism, islet capillary size as well as Pdx-1
and Nkx6.1 expression. Moreover, our data showed that β1 integrin primarily signals
through the FAK/MAPK/ERK cascade to regulate these physiological and
morphological parameters in vivo. This study increases our understanding of integrin
– ECM interactions and should prove very useful for cell-based therapies for the
treatment of diabetes.
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Figure 2-7 Signaling pathway activity in β1KO and control mice
Down-regulation of phospho-FAK/ERK1/2 signalling in β1 integrin-deficient mouse
pancreata. Western blot analyses of: (A) phosphorylated and total FAK; (B)
phosphorylated and total ERK1/2; (C) cleaved and total caspase-3; (D) cyclin D1; (E)
Pdx-1; and (F) phosphorylated and total Akt expression in the pancreas of male β1
integrin-deficient and control mice at 4 weeks post-injection. Representative blots are
shown. Data are normalized to the Cre+ controls (set at 1) and expressed as mean ± SE
(n = 3) ∗p < 0.05, ∗∗ p < 0.01 and ∗∗∗ p < 0.001 versus Cre+ controls. P,
phosphorylated; T, total: C, cleaved; KO, knockout; Ctrl, control.
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β1 integrin-extracellular matrix interactions are essential
for maintaining exocrine pancreas architecture and
function3

3
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3.1 Introduction
Integrin receptors have a significant role in cell–cell and cell–ECM contacts in many
different tissue types. There are 18 α and 8 β receptors capable of forming 24 heterodimeric
interactions; yet, half these interactions are made up by β1 integrin receptors [1]. This β1
integrin receptor group is largely responsible for attachment to the ECM [2]. Upon
stimulation, β1 integrin has been shown to mediate cell motility, survival, proliferation and
differentiation [2-5].
Pancreatic acini are enclosed round structures that produce digestive enzymes [6]. Basal
lamina covers the acini at the basal surface, stimulating acini integrin receptors [6].
Pancreatic stellate cells (PSCs) are identified as periacinar fibroblast-like cells of the
pancreas that express glial fibrillary acidic protein (GFAP) and produce ECM proteins in
support of surrounding tissue [7]. PSCs are also, in part, responsible for the fibrosis
observed in chronic pancreatitis [8, 9]. Previous studies have shown that α3β1 integrin is
essential for proper apical/basolateral cell surface receptor organization and basement
membrane formation in the submandibular gland [10]. As well, β1 integrin deficiency has
shown to interfere with laminin-1 expression and basement membrane synthesis and
assembly in embryoid bodies [11] and teratoma [12], as well as collagen IV expression in
the lens fiber of mice [13]. This is also true for proper fibronectin assembly, which requires
α5β1 integrin [14]. β1 integrin has been studied in many tissues, yet the role of β1 integrin
in the postnatal exocrine pancreas is almost wholly unknown. One recent study examined
the effect of loss of β1 integrin expression in acinar cells during development; 6-week-old
β1 integrin-deficient mice were susceptible to pancreatitis and displayed aberrant acinar
cell polarity and necrosis [15]. More recently, we have begun to probe the role of β1 integrin
expression in the postnatal, developed pancreas, using a tamoxifen-dependent cre
recombinase expressed under the control of a collagen I-specific promoter/enhancer.
We demonstrated that adult mice deficient in β1 integrin showed impaired glucose
tolerance with a significant reduction in pancreatic beta cell function, consistent with the
onset of diabetes. Furthermore, these β1 integrin-deficient mice displayed a significant
decrease in pancreatic FAK and ERK1/2 activation, along with increased caspase-3
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cleavage and decreased cyclin D1 expression [16]. However, the effects of β1 integrin
deficiency on pancreatic exocrine morphology and function in conditional β1 integrindeficient mice have still to be determined.
Here, we used mice homozygous for a loxP-β1 integrin allele and hemizygous for
tamoxifen-dependent cre recombinase expressed under the control of a collagen type I
promoter to analyze pancreatic exocrine morphology and function in vivo [16]. We
found that mice with β1 integrin deficiency controlled by the collagen I promoter had a
primary defect in PSCs and islets in the pancreas, which lead to a significant decrease in
ECM products in the exocrine compartment. β1 integrin-deficient mice displayed
significantly decreased food intake with a loss of body weight, which was associated with
reduced pancreatic amylase, carboxypeptidase A and regenerating islet-derived protein II
expression. These β1 integrin-deficient mice also demonstrated decreased exocrine cell
proliferation and increased apoptosis. Interestingly, cultured acinar cell clusters isolated
from β1 integrin-deficient mouse pancreata in the presence of ECM proteins showed an
improved acinar cell apoptosis. This study indicates that sufficient ECM and β1 integrin
interactions are essential for maintaining exocrine pancreatic integrity and function.

3.2 Materials and methods
3.2.1

Conditional β1 integrin-deficient mice

To generate conditional β1KO in collagen I-producing cells, floxed β1 integrin mice were
crossed with C57BL/6 mice containing CRE-ERT (tamoxifen-inducible cre recombinase)
gene downstream of the collagen type Ia2 (Col1a2) promoter, as described previously [17].
Progeny mice with positive genotype, as analyzed by PCR [17], were induced by
intraperitoneal injection of 1 mg tamoxifen (4-hydroxytamoxifen; Sigma, St Louis, MO,
USA) per mouse per day for 5 days at 3 weeks of age [16]. Corn oil-injected Cre- positive
and tamoxifen-injected Cre-negative mouse groups were merged as controls and
experiments were carried out on male mice at 4 and 7 weeks post-injection. Deletion of β1
integrin was confirmed by qRT-PCR, western blot and immunofluorescence as described
previously [16]. A Rosa26loxP-STOP-lacZ mouse (Jackson Laboratories), which does not
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express the β-galactosidase reporter gene unless cre recombinase is expressed in the
nucleus, was crossed with Col1a2-Cre-ERT to identify the cells within the pancreas that
expressed cre under control of the Col1a2 promoter [17]. All protocols were approved by
the Animal Use Subcommittee at the University of Western Ontario in accordance with the
guidelines of the Canadian Council of Animal Care (Appendix 1).

3.2.2

Body and pancreas weight and food intake studies

The body and pancreas weight of β1 integrin-deficient and control mice were measured at
4 and 7 weeks post-injection. At 4 weeks post-injection, mice from both β1 integrindeficient and control groups were separated individually and had their food weighed daily
at 0900 hours and monitored their food intake for a week. Data were expressed as average
food intake per mouse per day.

3.2.3

Acinar cell culture experiments

To isolate acinar cell clusters, both β1 integrin-deficient and control mouse pancreata at 3
weeks post-injection were dissected and digested with collagenase XI (1 mg/ml; Sigma).
Acinar cell clusters were cultured in modified RPMI 1640 media [18] with either 1% BSA
(Sigma) or 10% FBS (Invitrogen, Burlington, ON, Canada), reported to be enriched for
ECM proteins [19, 20], for 24 h. Cell clusters from four experimental groups (β1KO-BSA,
Ctrl-BSA,

β1KO-FBS,

and

Ctrl-FBS)

were

harvested

and

processed

for

immunofluorescence with at least four mouse pancreata per experimental per group used.

3.2.4

RNA extraction and real-time RT-PCR

Total RNA was extracted from pancreata of β1 integrin-deficient and control mice at 1
week post-injection using the miRNeasy kit (Qiagen, Germantown, MD, USA) [16]. For
each reverse transcription reaction, 2 mg of total RNA from whole pancreatic tissue were
used with oligo(dT) and random primers, as well as Superscript reverse transcriptase
(Invitrogen). Sequences of PCR primers used for RT-PCR with expected size of product
are listed in Appendix 5. A master mix of primers, water and SYBR green was made and
then added to separate tubes with each cDNA sample. Real-time RT-PCR analyses were
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conducted using the CFX manager software (Bio-Rad Laboratories, Mississauga, ON,
Canada) and CFX Connect Real-Time System (Bio-Rad Laboratories). Data were
normalized to levels of 18S RNA subunit and relative gene expression was calculated
based on the 2ΔΔCT method as PCR signals from β1 integrin-deficient pancreata relative
to controls.

3.2.5

Protein extraction and western blot analysis

β1 integrin-deficient and control pancreata, as well as acinar cell clusters, were sonicated
in Nonidet-P40 lysis buffer to extract protein. Equal amounts (2mg) of lysate pancreatic
proteins from each experimental group were separated by 10 or 20% sodium dodecyl
sulfate-polyacrylamide gel electrophoresis and transferred to a nitrocellulose membrane
(Bio-Rad Laboratories, Hercules, CA, USA). Membranes were incubated with appropriate
diluted primary antibodies listed in Appendix 4. Proteins were detected using ECL™-Plus
Western blot detection reagents (Perkin Elmer, Wellesley, MA, USA) and exposed using
the Versadoc Imaging System (Bio-Rad Laboratories). Densitometric quantification of
bands at subsaturation levels was performed using Quantity One software (Bio-Rad
Laboratories) and normalized to appropriate loading controls. Data are expressed as
relative expression level of protein to the loading control [16].

3.2.6

Serum assays for amylase and pancreatic lipase

Serum was collected from 7 week post-injected β1 integrin-deficient and control mice. To
measure serum amylase levels, a Phadebas Test tablet (Magle Life Sciences, Lund, SWE)
was added to diluted serum samples, based on the manufacturer’s instructions. Amylase
activity was measured with a spectrophotometer and determined by comparing absorbance
values to standard curve [21]. To examine the serum level of pancreatic lipase, serum
samples were mixed with lipase enzyme substrate and enzyme activator as per the
manufacturer’s instructions. Pancreatic lipase activity was measured using a
spectrophotometer and a formula offered by Genzyme Diagnostics (Charlottetown, P.E.I.,
CAN) [22].
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3.2.7

Extracellular matrix protein analysis

Pancreata from β1 integrin-deficient and control mice at 7 weeks post-injection were
dissected and fixed in 4% paraformaldehyde. Four μm thick pancreatic tissue sections were
prepared from the entire length of the pancreas and stained with hematoxylin and eosin,
Masson’s trichrome (for total collagen analysis), picrosirius red (for birefringent collagen
I staining), as described previously [16]. To quantitatively evaluate fibronectin
concentration in the pancreas of β1 integrin-deficient and control mice, a fibronectin mouse
sandwich ELISA kit was used (Abcam, Cambridge, MA, USA).

3.2.8

Immunofluorescence and TUNEL assay

Sets of pancreatic tissue sections (4 μm thick) were immunofluorescently stained with
appropriately diluted primary antibodies listed in Appendix 4. Fluorescent secondary
antibodies were obtained from Jackson Immunoresearch Laboratories (West Grove, PA,
USA) and 4'-6-Diamidino-2-phenylindole (DAPI, Sigma) was used for nuclear
counterstaining [16].
To assess the structural organization of focal adhesion contacts in pancreatic acinar cells,
an Actin Cytoskeleton and Focal Adhesion Staining kit (Chemicon, Temecula, CA, USA)
containing mouse anti-vinculin monoclonal antibody and TRITC-conjugated Phalloidin
was used. Cell proliferation was examined using Ki67 labeling (Abcam).
To examine the cells undergoing apoptosis, the terminal deoxynucleotidyl transferase
mediated nick end-labeling (TUNEL) assay was performed [23]. Briefly, pancreatic
sections were pretreated with 0.1% trypsin, then incubated with the TUNEL reaction
mixture conjugated with fluorescein-dUTP (Roche, Montreal, QUE, CAN). Percent cell
proliferation and apoptosis were calculated by counting Ki67 or TUNEL labeled cells in
exocrine tissue from at least 12 randomly selected fields of view per pancreatic section
[16].
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3.2.9

Statistical analysis

Data are expressed as means ± SE. Statistical significance was determined using the
unpaired student's t-test. Differences were considered to be statistically significant when
p<0.05.

3.3 Results
3.3.1

Loss of β1 integrin observed in pancreatic stellate cells and
islets with a significant reduction in ECM expression in the
pancreas of β1 integrin-deficient mice

To determine the pancreatic cell types that would be directly affected by the knockout of
β1 integrin, transgenic Rosa26loxP-STOP-lacZ mice were crossed with Col1a2-CRE(ER)T
mice [17]. The resultant mice were injected with tamoxifen to allow expression of βgalactosidase in cells specifically expressing cre recombinase under control of the Col1a2
promoter. Cells within the pancreas positive for β-galactosidase were detected with an antiβ-galactosidase antibody (Figure 3-1A). Double labeling using an antibody directed against
GFAP, a marker of PSCs [24] revealed that the Col1a2 promoter was active in PSCs
(Figure 3-1A). Moreover, β-galactosidase expression was also found in islets of the
pancreas (Figure 3-1A). These results indicate that these two cell populations express cre
recombinase under the control of the Col1a2 promoter.
To examine the effects of β1 integrin loss in PSCs and islets on pancreas function, mice
hemizygous for Col1a2-CRE-ERT and homozygous for loxP-β1 integrin were generated.
The resultant mice were injected with either tamoxifen or corn oil to generate mice deleted
or not for β1 integrin in PSCs and islets. To assess whether β1 integrin-deficient mice
pancreas showed altered ECM expression, quantitative RT-PCR (qRT-PCR) analysis of
collagen type Iα1 (Col1a1), collagen type Iα2 (Col1a2), fibronectin 1 (Fn1), laminin α1
(Lama1), laminin β1 (Lamb1) and laminin γ1 (Lamc1) mRNA was performed at 1 week
post-injection. We found a significant decrease in the expression of Col1a2 (p<0.001), Fn1
(p<0.05) and Lamc1 (p<0.05) mRNA in β1 integrin-deficient mice pancreata when
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compared to controls (Figure 3-1B-G). These results indicate that β1 integrin expression in
PSCs and islets regulates ECM gene expression.

3.3.2

Disturbed acinar cell-cell contacts and focal contact complex
observed in the β1 integrin-deficient mouse pancreas

Loss of β1 integrin in pancreatic PSCs and islets resulted in decreased ECM expression;
therefore, we set to investigate any alterations in pancreatic morphology. Based on
hematoxylin and eosin stain, we found that pancreatic acini similarly organized between
β1 integrin-deficient and control mice. However, the detachment of acini clusters from one
another was observed along with very basophilic stain in the periphery of the acinus in β1
integrin-deficient pancreata (Figure 3-2A). Masson’s trichrome (Figure 3-2B; upper panel)
and picrosirius red (Figure 3-2B; lower panel) staining revealed a reduction in collagen
fibers and connective tissue between the acini clusters. Furthermore, analysis of pancreatic
fibronectin protein levels in β1 integrin-deficient mice showed a significant decrease
compared to controls (p<0.05; Figure 3-2C). Actin cytoskeleton and focal adhesion
staining showed more robust cytoskeletal fibers along with more pronounced and
continuous vinculin stain in control, but not β1 integrin-deficient, mouse pancreas at 7
weeks post-tamoxifen injection (Figure 3-2D). Likewise, there was less co-locolization of
F-actin and vinculin suggesting fewer focal adhesions in 7 week post-tamoxifen injected
β1 integrin-deficient mice when compared to controls (Figure 3-2D). Finally, anti-laminin
immunofluorescence showed a dramatic loss of laminin in 7 week post-tamoxifen injected
β1 integrin-deficient mouse pancreas whereas controls show clear laminin at cell-cell
contacts (Figure 3-2E).
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Figure 3-1 Confirmation of β1 integrin knockout and extracellular matrix protein
expression
(A) Representative immunofluorescence images of the pancreas of a transgenic
Rosa26loxP-STOP-lacZ mouse crossed with a Col1a2-CRE-ERT mouse whereby the βgalactosidase reporter gene is expressed only if cre recombinase is present using antiGFAP, anti-β-galactosidase, and anti-insulin antibodies (arrows indicate colocalization of
GFAP and β-galactosidase, while arrowheads show no colocalization). (B) Relative mRNA
expression (normalized to 18S subunit) of Col1a1, Col1a2, Fn1, Lama1, Lamb1, Lamc1
of β1 integrin-deficient and control mouse pancreas at 1 week post-tamoxifen injection
(n=3-5). Data are expressed as means  SE. *p < 0.05, ***p < 0.001 vs. controls.
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3.3.3

Reduced β1 integrin in acinar cells, along with significantly
reduced pancreas weight and food intake observed in β1
integrin-deficient mice

Although the β-galactosidase stain showed a direct effect on PSCs and islets, but not acinar
cells in the β1 integrin-deficient mouse pancreas, reduced β1 integrin expression stain in
the acinar cell population was observed in 1 week post-tamoxifen injected β1 integrindeficient mice when compared to controls, but not at 3 days (Figure 3-3AB). Protein
expression analyses confirm these results, indicating a significant reduction in β1 integrindeficient mice at 7 days, but not 3, when compared to controls (p<0.05; Figure 3-3CD).
This suggests that loss of β1 integrin expression in the acinar cells may be secondary to the
loss of ECM proteins. Analysis of body and pancreas weight in 4 and 7 week posttamoxifen injected β1 integrin-deficient mice showed a significantly reduced ratio of
pancreas to body weight at 7 weeks post-injection when compared to control mice (p<0.05;
Figure 3-3E). As well, a significant decrease in food intake was observed in 4 week posttamoxifen injected β1 integrin-deficient compared to controls (p<0.001; Figure 3-3F).

3.3.4

Significantly reduced amylase expression observed in β1
integrin-deficient mice

To assess the defect of β1 integrin deficiency on exocrine pancreatic products, the
expression of amylase mRNA and protein, as well as serum amylase levels were examined.
We found that β1 integrin-deficient mice compared to controls had significant decreases in
amylase mRNA expression (p<0.05; Figure 3-4A), with 50% reduction of serum amylase
level (p<0.01; Figure 4B) and total amylase protein expression in the pancreas (p<0.05;
Figure 3-4D). Furthermore, serum pancreatic lipase activity was significantly reduced in
β1 integrin-deficient mice, but not controls (p<0.05; Figure 3-4C). Protein expression level
of CPA and Reg-II was also significantly decreased in β1 integrin-deficient pancreata when
compared to controls at 7 weeks post-injection (p<0.05-0.01; Figure 3-4EF), confirming
reduced pancreatic exocrine cell function in β1 integrin-deficient mice.
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Figure 3-2 Histological analysis of β1 integrin-deficient and control mice
(A) Hematoxylin and eosin, (B) picrosirius red (upper panels), and trichrome (lower
panels) staining of β1 integrin-deficient and control mouse pancreas at 7 weeks postinjection. Black arrows indicate positive collagen and connective tissue stain in controls
with fewer in β1 integrin-deficient mice. (C) Relative fibronectin concentration between
β1 integrin-deficient and control mice at 4 and 7 weeks post-injection (n=3-4). Data are
expressed as means  SE. *p < 0.05 vs. control. Immunofluorescence was used to
investigate focal adhesions (D) and laminin expression (E). Focal contacts are defined by
vinculin (green) and actin filaments by TRITC-conjugated phalloidin (red). Nuclei are
counterstained by DAPI (blue). Boxed regions display zoom, while arrows display cellcell contacts in focal adhesion and laminin immunofluorescence in control but not β1
integrin-deficient mouse pancreas. Scale bar = 100μm (A) and 50μm (B, D and E).
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3.3.5

Reduced β1 integrin in acinar cells led to significantly
increased cell apoptosis, which was partially rescued by
culturing acinar cell clusters with ECM proteins

To analyze the proliferative and apoptotic status of β1 integrin-deficient mouse pancreas,
Ki67 immunofluorescence staining and TUNEL was conducted. The percent of Ki67+
proliferating acinar cells was significantly decreased β1 integrin-deficient at 7 weeks posttamoxifen injection when compared to control mice (p<0.05; Figure 3-5A). Furthermore,
a significant increase in acinar cells undergoing apoptosis was observed in β1 integrindeficient mice (p<0.001; Figure 3-5B).
Since the primary β1 integrin defect is in PSCs and islets, we hypothesized that the
pancreatic exocrine dysfunction is due to problematic ECM stimulation of acini. To
investigate this, we isolated acinar cell clusters from control and β1 integrin-deficient
pancreata and cultured them with or without FBS that contains rich ECM proteins [19, 20].
β1 integrin-deficient acinar cell clusters cultured with BSA showed significantly increased
cell apoptosis when compared to the control cell clusters (p<0.05; Figure 3-5C). However,
the number of TUNEL-positive cells in β1 integrin-deficient acinar cell clusters was
reduced and reached control levels when cultured with FBS medium (p<0.05; Figure 35C).

3.4 Discussion
The present study analyzed the effects of β1 integrin deficiency on pancreatic exocrine
tissue. Our results demonstrate that β1 integrin deficiency under control of the collagen I
promoter directly effected PSCs and islets, and this lead to significantly reduced ECM
protein production in the pancreas. PSCs support parenchyma by secreting ECM
components that integrins use as ligands. Indeed, PSCs in human pancreatic acini stain
positive for collagen I, III and IV, laminin, fibronectin, and other ECM proteins [7].
Furthermore, there is a necessity of α5β1 integrin in connective tissue growth factor
stimulation of PSC collagen I synthesis [25]. It has also been reported that PSC secretion
of growth factors and ECM components are, in part, responsible for fibrosis in chronic
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Figure 3-3 β1 integrin expression is reduced in acinar cells
Representative immunofluorescence images of β1 integrin-deficient and control mouse
pancreas at 3 (A) and 7 days (B) post-tamoxifen injection using an anti-β1 integrin
antibody. Western blot analyses of β1 integrin-deficient and control mouse β1 integrin
expression at 3 (C) and 7 days (D) post-tamoxifen injection (n=4). (E) Pancreas to body
weight ratio in β1 integrin-deficient and control mice at 4 and 7 weeks post-injection (n=717). (F) Food intake data from 4 week post-tamoxifen injected β1 integrin-deficient mice
with respective controls (n=7-8). Data are expressed as means  SE. *p < 0.05; ***p <
0.001 vs. controls. Scale bar = 50μm.
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pancreatitis [8, 9]. Our results support previous research, in that β1 integrin is required to
maintain PSC expression of certain ECM proteins, including Col1a2, Fn1 and Lamc1.
Our observation of reduced pancreatic ECM mRNA was concomitant with disrupted cellcell contacts between acini along with reduced connective tissue and collagen fibers,
laminin immunoreactivity and acinar cell expression of β1 integrin. It is unclear precisely
which process preceded the other, but studies have demonstrated that β1 integrin loss lead
to improper basement membrane assembly and laminin expression in teratoma [12] and
embryoid bodies [11], implicating β1 integrin as an essential part of ECM maintenance. It
has also been demonstrated that ECM proteins can regulate integrin expression in human
fibroblasts [26]. Ablation of β1 integrin by inactivating monoclonal antibody treatment
disrupted cell-cell contacts of keratinocytes [27]. Likewise, mouse mammary gland alveoli
deficient of β1 integrin could not attach to the basement membrane laminin substratum
[28]. This study also showed decreased focal adhesion contacts in β1 integrin-deficient
mammary epithelium when compared to controls [27]. Taken together, the findings of this
study demonstrate that reduced β1 integrin in PSCs had a direct effect on ECM expression,
which in turn, effected acinar cell β1 integrin expression, cell-cell interactions, and
subsequently cell proliferation and death.
β1 integrin has been well-established as upstream of the mitogen-activated protein kinase
(MAPK) pathway, which has profound effects on cell survival and proliferation [16, 23].
Our previous analysis of β1 integrin-deficient mice demonstrated a significant reduction in
FAK and ERK1/2 phosphorylation, indicating reduced MAPK signaling [16]. The present
results corroborate these studies by demonstrating a reduction in pancreatic β1 integrin,
along with significantly decreased proliferation and increased apoptosis. To elucidate if the
observed effects of pancreatic exocrine dysfunction were due to β1 integrin or ECM protein
deficiency, isolated exocrine cell clusters from β1 integrin-deficient and control mouse
pancreas were cultured in ECM-enriched medium. Our data indicate that apoptosis was
significantly reduced in β1 integrin-deficient cell clusters when cultured in media with
FBS, suggesting that supplementing ECM proteins to β1 integrin-deficient cell clusters can
improve their survival status. This strengthens our working model, whereby pancreatic
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Figure 3-4 Exocrine protein expression in β1 integrin-deficient and control mice
(A) qRT-PCR analysis of amylase mRNA expression in 1 week post-injected β1 integrindeficient and control mouse pancreas (n=3). Analysis of serum (B) and pancreatic protein
(D) amylase and serum pancreatic lipase (C) in 7 week post-injected β1 integrin-deficient
and control mice (n=3-10). Relative carboxypeptidase-A (D) and Reg-II (E) protein
expression in the pancreas of 7 week post-injected β1 integrin-deficient and control mice
pancreas (n=4). Data are expressed as means  SE. *p < 0.05, **p < 0.01 vs. controls.
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exocrine defects associated with β1 integrin deficiency may be largely due to insufficient
ECM proteins.
It was noted that food intake was significantly reduced in β1 integrin-deficient at 4 weeks
post-tamoxifen injection along with a significant decrease in body weight [16]. Many
studies have established a positive correlation between food consumption and weight gain
[29, 30]. Food intake is controlled by a brain-gut axis associated with multiple factors
including pancreatic enzyme secretion [31-33]. Our data demonstrated a significant
reduction in pancreatic lipase, amylase and CPA expression, major enzymes produced by
the exocrine pancreas, in β1 integrin-deficient mice when compared to controls, suggesting
that the pancreatic insufficiency occurred due to the loss ECM proteins and β1 integrin in
the pancreas. The pancreas of β1 integrin-deficient mice became significantly underweight
at 7 weeks post-tamoxifen injection [16], which was more drastic than the drop in body
weight as shown by the ratio of pancreas to body weight. This ratio was significantly
decreased in β1 integrin-deficient mice when compared to controls further indicating a
severe pancreatic defect. Meanwhile, other research has shown that reduction in food
intake decreases serum [32] and pancreatic [33] amylase, which may be related to lower
insulin levels. These studies are in line with our research, whereby β1 integrin-deficient
mice display reduced pancreatic insulin along with reduced serum amylase activity and
pancreatic amylase protein and mRNA expression [16]. Therefore, the lack of pancreatic
ECM proteins or β1 integrin affected pancreatic enzyme levels, which may have negatively
affected food intake, and thus body weight.
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Figure 3-5 Cell proliferation and death is altered in β1 integrin-deficient mice
Quantitative analysis of cell proliferation (A) and apoptosis (B) in the exocrine pancreas
of β1 integrin-deficient and control mice at 7 weeks post-injection. (C) Apoptosis in
exocrine cell clusters cultured in either BSA or FBS for 24 hours. The percentage of Ki67
or TUNEL positive cells over total number of cells counted was calculated and data are
expressed as means  SE (n=4). *p < 0.05, ***p < 0.001 vs. controls.
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In summary, β1 integrin-deficient mice showed significant pancreatic exocrine dysfunction
compared to controls. The decrease in pancreas to body weight ratio, essential pancreatic
digestive enzymes and ECM matrix expression all suggest that β1 integrin and ECM
proteins have an important role in maintaining pancreatic function and differentiation.
Furthermore, we observed increased cell death and reduced cell proliferation, indicating
disturbed cell survival/apoptosis homeostasis. A recovery in apoptosis was observed after
β1 integrin-deficient cell clusters were provided ECM proteins. Taken together, these
results implicate β1 integrin as an essential component to maintain ECM expression along
with exocrine pancreatic structure and function.
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Chapter 4

4

Fibrin improves beta (INS-1) cell function, proliferation
and survival through integrin αvβ34

4
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4.1 Introduction
Diabetes Mellitus is a debilitating disease of glycemic dysfunction with increasing
prevalence. Islet transplantation is a viable means to cure diabetes, however, donor
shortage is a significant limitation due to the low yearly number of available donor
pancreata [1]. As well, the current islet transplant regimen requires two donor pancreases
to reverse diabetes [2]. To overcome such an obstacle, researchers have looked towards
using other types of donors [3], generating beta cells from different cell types (either fully
differentiated cells [4], or beta cell precursors [5]), or methods to maintain existing beta
cell proliferation and function [6].
Of critical importance to islets and beta cells is the maintenance of ECM-integrin
interactions. Integrins are a group of cell adhesion receptors that have profound influences
on beta cell survival [7], differentiation [8] and function [9]. Upon engagement by ECM
proteins, including fibronectins, collagens, and/or laminins, integrins activate and mediate
intracellular signaling cascades [10]. Isolated islets cultured with an RDG peptide, type IV
collagen or laminin significantly reduced cell death [11]. As well, canine islets cultured
with type I collagen improved GSIS and islet insulin content while increasing cell survival
[7]. Likewise, laminins are as an essential part of the islet basement membrane that
mediates islet β1 integrin activity [12]. Culture of facultative liver stem cells (hepatic oval
cells) with laminin induced the expression of Pdx-1, Pax-6, insulin and glucagon,
indicating that laminin may influence islet cell differentiation [13]. Antibody inhibition of
β1 integrin and laminin-5 interactions led to a significant reduction in beta-cell spreading
and GSIS when compared to controls [14]. Fibronectin contains RGD domains that are
preferentially bound by a large group of integrins. When immortalized rat insulinoma cells
(INS-1) were cultured on fibronectin and RGD peptides, GSIS was significantly enhanced
compared to controls [15]. While each of these ECM proteins is a viable means to improve
short-term islet health in vitro, they are unable to maintain this benefit for long-term, nor
can they easily form a 3D scaffold for in vivo transplantation [16].
Fibrin is a provisional ECM protein essential for clotting in mammals. Originally from the
liver, fibrinogen is cleaved to fibrin by thrombin and undergoes polymerization (reviewed
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in [17]). This can be taken advantage of, in vitro, to form gels that are biocompatible [18],
biodegradable [19], able to support 3D scaffolds [20] and promote angiogenesis [21].
Fibrin also contains RGD amino acid motifs that are essential for binding integrin receptors
such as αvβ3 [22]. As well, fibrin can enhance adult human islet function and survival [23]
and subcutaneous transplantation of fibrin-cultured islets in diabetic mice significantly
enhanced glucose tolerance [24]. However, the mechanism behind fibrin’s ability to
promote beta cell health is unclear. The current research analyzed the necessity of integrins
involved in promoting beta cell function, proliferation and survival under fibrin culture.

4.2 Materials and methods
4.2.1

INS-1 cell culture and fibrin gel preparation

One million INS-1 (832/13, a gift from Dr. Christopher Newgard, Duke University Medical
Center, USA) cells per well were cultured in RPMI-1640 containing 10% fetal bovine
serum (Invitrogen, Burlington, ON, CAN) [25]. A fibrinogen solution (1.8mg/ml) was
mixed with thrombin (Sigma, St Louis, MO, USA), to initiate polymerization. This
resultant solution was then quickly administered to wells of a 24-well plate. INS-1 cells
plus medium were then added on top of fibrin gel for the 2D experimental group, while the
3D fibrin-cultured group had INS-1 cells added to the fibrinogen solution prepolymerization. Three INS-1 cell experimental groups, tissue culture polystyrene (TCPS),
2D fibrin and 3D fibrin, were cultured for 1, 2 and 4 weeks, then samples were collected
for analyses.

4.2.2

Glucose-stimulated and basal insulin secretion

Overnight media samples were collected from duplicates of INS-1 cells from each
experimental group for basal insulin secretion levels. Meanwhile, duplicates of INS-1 cells
from each experimental group were incubated with RPMI1640 culture media with 1%
bovine serum albumin containing either 2.2 mmol/l or 22 mmol/l glucose for 2 hours to
analyze GSIS. All collected samples were analyzed by a highly sensitive rat insulin ELISA
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(Alpco, Salem, NH, USA). A static GSIS index was calculated [26], while basal insulin
secretion was expressed as nanogram per ml.

4.2.3

Scanning electron microscopy

Fibrin-cultured INS-1 cells were fixed with 2.5% glutaraldehyde at 4°C overnight, then
dehydrated with an increasing concentration gradient of ethanol. Three-dimensional fibrin
samples were cut with scissors to expose cells. Samples were subjected to critical point
drying and gold coating, and then visualized by a Hitachi 3400-N Variable Pressure
Scanning Electron Microscope.

4.2.4

Integrin αvβ3 blockade using an immunoneutralizing antibody

INS-1 cells were preincubated with either mouse anti-αvβ3 integrin antibody or IgG
isotype-matched negative control (10μg/ml; Abcam, Cambridge, MA, USA) for 1 hour
then plated on 2D fibrin gels for 24 hours. Cells were then photographed and harvested for
analyses.

4.2.5

RNA extraction and real-time RT-PCR

Total RNA was extracted from 1 week fibrin-cultured INS-1 cells and controls using the
miRNeasy kit (QAIGEN, Germantown, MD, USA). Briefly, samples were washed then
added to a volume of QIAzol lysis reagent. After vortexing, an equal volume of ethanol
was added, and samples were spun through the RNeasy Mini Spin Column. After a series
of washes, RNA on the column was eluted using hot elution buffer.
For each reverse transcription reaction, 2 μg of DNA-free RNA was used with random
hexamers/oligo-deoxythymidine

primers

and

Superscript

reverse

transcriptase

(Invitrogen). Sequences of PCR primers used for RT-PCR with expected product size are
listed in Appendix 5. A master mix of primers, water and SYBR green was made and then
added to separate tubes with each cDNA sample. Real-time RT-PCR analyses were
conducted using the CFX manager software (Bio-Rad Laboratories, Mississauga, ON,
Canada) and CFX Connect Real-Time System (Bio-Rad Laboratories). Data were
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normalized to levels of 18S rRNA subunit and relative gene expression was calculated
based on the 2ΔΔCT method as PCR signals from 2D and 3D fibrin-cultured INS-1 cells
normalized to TCPS controls.

4.2.6

Immunofluorescence and TUNEL assay

INS-1 cells at the end of the culture period were collected and fixed in 4%
paraformaldehyde overnight, then agarose embedding and wax processing was undertaken.
The sections (4 μm thick) were prepared and stained with appropriate dilutions of primary
antibodies listen in Appendix 4. Fluorescent secondary antibodies were obtained from
Jackson Immunoresearch Laboratories (West Grove, PA, USA). Percent co-localization of
Pdx-1 or Ki67 with insulin was calculated by double immunofluorescence staining, and
then cell counting of Pdx-1 or Ki67 positivity in insulin positive cells.
The TUNEL assay was performed to examine cells undergoing apoptosis [28]. INS-1 cell
sections were incubated with the TUNEL reaction mixture conjugated with fluoresceindUTP (Roche, Montreal, QC, Canada) and anti-insulin antibodies (Zymed). The percent
cell apoptosis was calculated by counting TUNEL-labeled cells in insulin-positive cells.

4.2.7

Protein extraction and western blot analysis

Fibrin-cultured and control INS-1 cell protein was extracted in Nonidet-P40 lysis buffer.
Equal amounts (15 μg) of lysate protein from each experimental group was separated by
either 7.5, 10 or 12% sodium dodecyl sulfate-polyacrylamide gel electrophesis and
transferred to a nitrocellulose membrane (Bio-Rad Laboratories, Mississauga, ON,
Canada). Membranes were incubated with appropriate dilutions of primary antibodies
listed in Appendix 4. The application of appropriate horseradish peroxidase-conjugated
secondary antibodies (Santa Cruz Biotechnologies, Santa Cruz, CA, USA) then followed.
Proteins were detected using ECL™-Plus Western blot detection reagents (Perkin Elmer,
Wellesley, MA, USA) and exposed using the Versadoc Imaging System (Bio-Rad
Laboratories). Densitometric quantification of bands at subsaturation levels was performed
using Quantity One software (Bio-Rad Laboratories) and normalized to appropriate
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loading controls. Data are expressed as the relative expression level of phosphorylated
proteins to total protein levels or protein levels to the loading control [29].

4.2.8

Statistical analysis

Data are expressed as means ± SE using at least 3 to 4 different cell passages per
experimental group, representing n = 3-4. Statistical significance was determined using
either the unpaired student's t-test or one-way ANOVA followed by post hoc least
significant differences and Bonferroni comparison test. Differences were considered
statistically significant when p<0.05.

4.3 Results
4.3.1

INS-1 cells form islet-like clusters and interact with fibrin when
cultured with fibrin gels

INS-1 cells were cultured on TCPS, 2D and 3D fibrin for periods of 1, 2, and 4 weeks.
After 1 week, INS-1 cells began to form small clusters on 2D and in 3D fibrin gels and
expanded significantly at 2 weeks of culture, while cells cultured on TCPS grew as a
monolayer (Fig. 4-1A). After 4 weeks, robust islet-like clusters in fibrin-cultured INS-1
cells were often observed (Fig. 4-1A). It was noted that both TCPS and 2D fibrin gelcultured INS-1 cells had more dark spots associated with the clusters compared to 3D fibrin
after 4 week of the culture (Fig. 4-1A).
Scanning electron microscopy revealed contacts between fibrin gels and INS-1 cells in both
2D and 3D cultures after 1 week (Fig. 4-1B). Cells cultured in 3D fibrin were enveloped
in fibrin fibers and showed frequent contacts between the cells and fibrin; however, cells
on 2D fibrin were only connected to fibrin at the basal surface (Fig. 4-1B, white arrows).
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Figure 4-1 Fibrin promoted islet-like cluster formation.
(A) INS-1 cells cultured on TCPS, on 2D and in 3D fibrin for 1, 2 and 4 weeks. Scale bars:
100μm (B) Scanning electron micrographs of fibrin-cultured INS-1 cells. White arrows
indicate examples of areas of fibrin-cell contacts. Scale bars: 5μm, 2μm, 2μm for 2D fibrin,
3μm, 1μm and 1μm for 3D fibrin.
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4.3.2

Significantly improved insulin secretion function observed in
INS-1 cells when cultured with fibrin

Basal insulin secretion of INS-1 cells was significantly increased in 2D fibrin after 4 weeks
of culture, with a relative increase in 3D fibrin culture (Fig. 4-2A). A significant increase
in GSIS was observed in 2D and 3D fibrin-cultured cells 2 weeks (Fig. 4-2B). Furthermore,
GSIS of 3D fibrin-cultured INS-1 cells was 4-fold higher compared of TCPS controls after
4 weeks (Fig. 4-2B). While there was a similar effect in the 2D fibrin group, statistical
significance was not attained when compared to TCPS culture (Fig. 4-2B).
INS-1 cells also maintained their differentiated state when cultured in fibrin as opposed to
TCPS controls. Real-time RT-PCR analyses of important beta cell genes indicated a
significant increase in the Ins1 gene after 1 week of 3D-fibrin culture (Fig. 4-2C). The
protein level of Pdx-1 was significantly higher in INS-1 cells cultured with fibrin for 4
weeks, but not 1 week (Fig. 4-2D). This increase was associated with higher co-localization
of Pdx-1 and Insulin in INS-1 cells cultured with fibrin at 1 and 4 weeks compared to
controls (Fig. 4-2E).

4.3.3

Integrin αv and β3 expression plus intracellular pathway
signaling was significantly increased in fibrin-cultured INS-1
cells

Since fibrin contains RGD amino acid motifs, integrins receptors that preferentially bind
to RGD domains such as v associated with 1, β3 and β5, as well as 1 associated with
3, α5 and α8 were examined. Real-time RT-PCR analysis of integrin mRNA showed a
relative increase in a number of integrin receptors in fibrin-cultured INS-1 cells after 1
week, yet statistical significance was not reached (Fig. 4-3A). Fibrin-cultured INS-1 cells
showed significantly higher protein levels of integrins αV and β3, at 1 and 4 weeks of
culture when compared to TCPS controls (Fig. 4-3B). However, protein expression of
integrin α3 and β1 was relatively unchanged (Fig. 4-3C). The increases in integrin protein
expression in fibrin-cultured INS-1 cells was associated with a significant increase in
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Figure 4-2 Fibrin improved INS-1 cell function and increased Pdx-1 expression.
(A) Basal insulin secretion of INS-1 cells cultured with fibrin or on TCPS. (B) INS-1 cell
function as measured by glucose-stimulated insulin secretion in fibrin-culture of up to 4
weeks. (C) Relative mRNA expression of important beta cell genes in INS-1 cells cultured
with fibrin or on TCPS for 1 week. Western blot analysis (D) and the percent of Pdx1/insulin positive cells labeled by double immunofluorescence stain of Pdx-1 (green) with
insulin (red) (E) in fibrin or on TCPS cultured INS-1 cells. Magnified images for each
corresponding image are shown in the insert. Data are expressed at means ± SE (n=3-5).
Representative blots are shown. Arrows indicate double positive cells and scale bar: 50μm.
*p<0.05, **p<0.01 and ***p<0.001 vs. TCPS control.
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phosphorylated focal adhesion kinase (FAK), extracellular-signal regulated kinase 1/2
(Erk1/2) and Akt activity at 4 weeks compared to controls (Fig. 4-3DEF).

4.3.4

Significantly improved cell proliferation and decreased cell
death observed in INS-1 cells when cultured with fibrin

INS-1 cells cultured with fibrin at 1 and 4 weeks showed a significant increase in beta cell
proliferation as labeled by Ki67 and insulin (Fig. 4-4A). As well, cyclin D1 was
significantly increased in fibrin-cultured INS-1 cells at 4 weeks of culture (Fig. 4-4B).
Cleaved caspase 3 level was significantly reduced in both 2D and 3D fibrin-cultured INS1 cells at 1 and 4 weeks of culture (Fig. 4-4C), and this was associated with a decrease in
the number of insulin positive cells labeled by TUNEL (Fig. 4-4D).

4.3.5

Blockade of integrin αvβ3 increased cell death observed in
INS-1 cells when plated on 2D fibrin

To understand the necessity of integrin αvβ3 and fibrin interactions for cell survival, INS1 cells were treated with an anti-integrin αvβ3 blocking antibody then plated on 2D fibrin.
After 24 hours, anti-αvβ3 treated INS-1 cells displayed a decrease in spreading on the fibrin
gel (Fig. 4-5A). Activated FAK was downregulated by about 50% (Fig. 4-5B) but there
were no changes in Erk1/2 and Akt phosphorylation, cyclin D1 or Pdx-1 expression (data
not shown). There was, however, a significant increase in cleaved caspase-3 compared to
both controls (Fig. 4-5C).

4.4 Discussion
This study investigated how fibrin can promote beneficial effects in beta cells. Long-term
fibrin culture of INS-1 cells led to improved insulin secretion in response glucose
stimulation and increased Pdx-1 protein expression compared to controls. Fibrin-cultured
INS-1 cells also showed significantly improved cell proliferation and reduced cell death.
This was associated with increased integrin αvβ3 expression and activity of downstream
signal transduction pathways (FAK, Erk 1/2 and Akt). Finally, blockade of integrin αvβ3
led to significant decreases in activated FAK along with significantly increased caspase-3
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Figure 4-3 Fibrin induced integrin αvβ3 expression.
(A) Relative mRNA expression of integrin receptors in INS-1 cells cultured for 1 week
with fibrin or on TCPS. Western blot analysis of integrins αv and β3 (B), α3 and β1 (C)
and phosphorylated FAK (D), Erk1/2 (E) and Akt (F) in INS-1 cells cultured with fibrin or
on TCPS for 1 and 4 weeks. Data are expressed at means ± SE (n=3-5). Representative
blots are shown. *p<0.05, **p<0.01 and ***p<0.001 vs. TCPS control. p: phosphorylated;
t: total.
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cleavage in fibrin-cultured INS-1 cells. Fibrin culture of INS-1 cells led to significantly
increased insulin secretion in response to glucose challenge at 2 and 4 weeks of culture.
Our study is unique from other research that showed a significant improvement in GSIS
after 7 days [23]. However, that study used adult human islets, and also cultured them with
hepatocyte growth factor, which may have assisted beta cells to function optimally while
cultured with fibrin [23]. Another study cultured human pancreatic islets in 3D gels
supplemented or not with ECM components for 10 days and observed improvements to
islet gene expression [30]. Furthermore, when INS-1 cells were cultured with fibronectin
or RGD peptides for 7 days, there was an improvement in cell growth and GSIS [15]. We
did not observe significant changes in INS-1 cell function after one week culture on either
2D or 3D when compared to TCPS culture, but phospho-FAK and ERK signaling
molecules were slightly increased. These results suggest that: (i) fibrin may not directly
influence beta cells, but rather maintains their functional status during long-term culture
better than TCPS culture and/or (ii) INS-1 cells cultured on TCPS do not require ECM
support for short-term culture due to its cancer cell phenotype. We also observed that 2D
fibrin-cultured INS-1 cells had significantly higher basal insulin secretion, as opposed to
GSIS, in which INS-1 cells cultured in 3D fibrin had the greatest increase. A major
difference between 2D and 3D cultured cells is their morphology and polarization. Cells
grown in 2D are flat, proliferate into a monolayer and are forced into an apical-basal
polarity, while 3D-cultured cells form stellate-like clusters [31]. These changes in cell
shape and polarity are able to modulate cellular activity, including protein synthesis and
function [32]. There have also been reports that a 3D ECM environment can sequester and
limit the transport of soluble factors [33]. In this manner, it is possible that under basal
conditions, insulin is either held within fibrin, or that the 3D cell morphology is not
conducive to insulin release without stimuli. However, under high glucose conditions, 3D
fibrin-cultured INS-1 cells are able to overcome the barrier associated with fibrin and
release insulin in a significant manner.
In the short-term, we observed increases in integrin expression with slight increased
phospho-FAK and ERK1/2; however, significant differences in signaling pathway
activation were detected during long-term 4 week culture. This lag may be due to the
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Figure 4-4 Fibrin improved cell proliferation and survival
The percent of Ki67/insulin positive cells determined by double immunofluorescence
staining for Ki67 (green) and insulin (red) (A), western blot analysis of cyclin D1 (B) and
cleaved caspase-3 (C) in INS-1 cells cultured with fibrin or on TCPS for 1 and 4 weeks.
(D) The percent of beta cell death labeled by TUNEL (green) with insulin (red) staining in
INS-1 cells cultured with fibrin or on TCPS for 1 week. Arrows indicate proliferating beta
cells, scale bar: 50μm. Data are expressed at means ± SE (n=3-4). Representative blots are
shown. *p<0.05, **p<0.01 and ***p<0.001 vs. TCPS control.
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intricate nature of integrins, which have their activation dictated by the talin protein [34].
As well, there could be a threshold of integrin receptors required before a substantial signal
can be transduced to downstream protein kinases, which we observed after long-term fibrin
culture. Finally, it is also possible that after 4 weeks of culture, maintenance of integrin
receptor expression is greatly dimished in TCPS-cultured INS-1 cells. This may have been
prevented in fibrin culture, which allowed cells to thrive functionally and maintain
expression of Pdx-1, cyclin D1 and phosphorylated signaling members.
In our study, improvements in beta cell function were associated with increased integrin
expression, signaling pathway activity, cell proliferation and reduced cell death after 4
weeks of culture. INS-1 cells cultured on TCPS form a monolayer after 4 weeks, as
opposed to fibrin, which stimulates an islet-like clustering. This clustering itself may have
been a factor that enhanced function [35]. One group has reported successful islet culture
for up to 6 months in a specialized 3D suspension serum-free media [36] and demonstrated
reversal of diabetes when post-cultured islets were transplanted into streptozotocin-treated
mice [37]. These cultures are without ECM supplementation and it is unknown how this
media functions to improve islet cell viability; however, culture in 3D suspension has been
demonstrated to improved islet viability [38]. Integrin receptors besides αvβ3 may have
been involved, as well as other receptors that have been shown to bind fibrin, yet not been
characterized in beta cells such as CD44 [39]. The complete mechanism of action of
fibrin’s effects on INS-1 cells is still unknown, since blocking integrin αvβ3 immediately
showed a change in cleaved caspase-3. This suggests that changes in INS-1 cell function
and proliferation are due to long-term stimulation of integrin αvβ3 or mediated by other
cell receptors.
The up-regulation of integrin receptors was associated with significantly increased
phosphorylated FAK and Erk/2, which can activate the insulin promoter, as well as
important beta cell transcription factors like Pdx-1, Beta2 or MafA [40, 41]. INS-1 cells
cultured with 2D and 3D fibrin showed increased Pdx-1 expression, suggesting that it
might be due to active Erk1/2 modulation. Akt was also increased in fibrin-cultured INS-1
cells. The PI3K/Akt pathway has been shown to activate Pdx-1, promote beta cell survival,
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Figure 4-5 Integrin αvβ3 blockade led to increased cell death when INS-1 cells were
cultured on 2D fibrin.
(A) Brightfield microscope images and (B) western blot analysis of focal adhesion kinase
activity and caspase-3 cleavage in INS-1 cells treated with or without an anti-αvβ3
blocking antibody for 24 hours. Scale bar: 100μm. Data are expressed at means ± SE (n=4).
Representative blots are shown. *p<0.05 and ***p<0.001 vs. untreated control.
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and increase proliferation by increasing cyclin D1 expression [42-44]. Fibrin culture of
INS-1 cells led to up-regulation of certain integrins, namely αvβ3. Fibrin contains RGD
domains, which can be bound by integrin αvβ3 [45] and this ECM-mediated integrin
regulation has previously been shown in vascular smooth muscle cells [46]. Scanning
electron microscopy revealed clear contacts between INS-1 cells and fibrin fiber
projections (Fig. 4-1B), suggesting that cell adhesion receptors including intgerins are
stimulated. We sought to block αvβ3 integrin-ECM interactions, in hopes of determining
a mechanism behind fibrin-mediated improvements to beta cell function, proliferation and
survival. In αvβ3 integrin-blocked cells, there was a significant reduction in phospho-FAK
expression, suggesting that FAK signaling pathways are mediated by integrin αvβ3;
however, there were no changes in Erk1/2 and Akt activation. The reasons for this could
be that the blockade was not long enough to affect these pathways in a significant way.
Also, other integrins could be compensating for reduced αvβ3 activity by maintaining
Erk1/2 and Akt activity through a different means such as integrin-linked kinase, observed
in cardiomyocytes and mammary epithelial cells [47, 48]. Cleaved caspase-3 was
significantly increased in integrin αvβ3-blocked INS-1 cells, suggesting that interactions
between integrin αvβ3 and fibrin may have a primary role in maintaining INS-1 survival
via FAK signaling pathways. The other signaling pathway members that contribute to beta
cell health via fibrin-integrin interactions remain to be investigated.
Previous work has shown that blockade of a more promiscuous integrin, β1, led to a
significant decrease in human fetal pancreatic cell phospho-FAK, phospho-Erk1/2 with
increased cleaved caspases 9 and 3 [49]. Likewise, blocking β1 integrin receptors on INS1 cells during collagen culture reduced cell adhesion as well as Pdx-1 and insulin
expression [25]. β1 integrin can pair with various α integrin subunits, which makes it much
more detrimental to cells when blocked. When αvβ3 integrin was blocked in endothelial
cells and fibroblasts, there were inhibitions in VEGF signaling and cell motility [50]. The
role of αvβ3 integrin in angiogenesis has been well-characterized [51]; yet, in the context
of other integrins, there is complex cross-talk between integrins that influences how cells
will behave [52]. This cross-talk may be an important factor to consider with respect to the
effects of fibrin-cultured beta cells.
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4.5 Conclusions
Fibrin is a provisional ECM protein that improves beta cell function, proliferation and
survival. Fibrin also increases integrin expression, which may be the mechanism behind
the beneficial effects we observed in beta cells. At least one integrin receptor, αvβ3, plays
a role in mediating beta cell survival when cells are cultured on fibrin. Understanding how
fibrin promotes beta cell health is essential to improve upon therapies for diabetes
treatment. Treatments such as islet transplantation are only effective if there is a sufficient
supply of beta cells and this supply can be increased if beta cell integrin-ECM interactions
are understood.
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5.1 Introduction
Islet transplantation for the treatment of diabetes is currently limited by a shortage of
available donor pancreata [1]. In order to surpass this problem, generating beta cells from
progenitor cell sources is a viable option [2]. However, this procedure and others like it
produce low numbers of effective, functional beta cells [2]. A greater understanding of the
factors, especially those in the microenvironment, which regulate pancreatic development
and islet cell differentiation are required to significantly increase the yield of beta cells that
these procedures generate for islet transplantation.
Human pancreatic development begins at day 26 post-conception, with tubular structures
protruding from the ventral and dorsal side of the foregut endoderm. Two transcription
factors that are required for the initiation of pancreatic development are PTF-1A and PDX1 [3], in which the latter also promotes beta cell maturation and function [4]. By 8 weeks
of age, Sry-related HMG box 9 (SOX9) is expressed in the pool of pancreatic progenitors
[5] and is essential to support their proliferation and survival as well as maintain a
transcriptional network with other factors [6]. SOX9 is also an important regulator of
pancreatic endocrine cell differentiation [5]. Insulin positivity emerges around 7.5 weeks
post-conception, followed by glucagon and somatostatin one week later [7]. Islet-like
structures eventually form where cells commonly express more than one hormone [7].
Subsequently, clustering occurs leading to construction of the islet of Langerhans [8, 9].
Cell receptors in the human fetal pancreas that promote interactions with the ECM are
integrins. Integrins are a family of highly expressed heterodimeric alpha and beta receptors
that bind to motifs of laminin, collagen, fibronectin and other cell surface receptors [10].
Integrins modulate multiple cellular processes in a variety of tissues. In the mouse
pancreas, the conditional removal of β1 integrin leads to dysfunction of the endocrine [11]
and exocrine [12] compartments. Removal of β1 integrin in developing pancreatic beta
cells leads to a massive reduction in insulin positive cells and cell cycle progression genes,
suggesting that beta cell expansion relies upon β1 integrin and ECM interactions [13].
Meanwhile, studies with human fetal pancreas indicate that integrins α3, α5 α6 and their
associated β1 counterpart are present by 8 weeks of age, and increase as development
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continues [14, 15]. Also, integrins αv with β1, β3 and β5 are important for human fetal beta
cell adhesion and motility [16-18]. Knockdown of integrin receptors in human fetal
pancreatic cells show that β1 integrin is required for maintenance of insulin expression,
cell survival and adhesion [14, 18]. Likewise, loss of α3 integrin function leads to decreased
intracellular signaling, adhesion to ECM proteins and insulin expression in human fetal
pancreatic cells [19]. In this way, integrin receptors are important components of the human
fetal pancreas, especially in regards to insulin expression and islet development.
Fibrin is a protein found in blood clots. Derived from fibrinogen following activation of
the coagulation cascade and cleavage by thrombin, fibrin forms crosslinks to form a clot
[20]. Fibrin also contains the amino acid motif RGD, a ligand to a large group of integrin
receptors [21]. Addition of an RGD peptide to culture has been shown to significantly
reduce islet cell death [22]. Culture of the adult rat insulinoma cell line, INS-1, with RGD
peptides, fibronectin and fibrin gels lead to significant improvements in glucose-stimulated
insulin secretion and proliferation [23, 24]. Blockade of αvβ3 integrin by a neutralizing
antibody resulted a significantly increased beta-cell apoptosis, indicating that functional
αvβ3 integrin is required for beta-cell survival [24]. Furthermore, 3D fibrin culture of
isolated human islets significantly enhanced beta cell function and survival [25]. Fibrin is
able to support a 3D cellular environment [26] and promote angiogenesis [27], which may
be beneficial for human fetal pancreatic islet cell growth and maturity during culture and/or
transplantation [7].
Transplantation of human fetal pancreata has been suggested as a treatment alternative for
diabetes due to its reduced immunogenic nature [28]. Indeed, transplantation of human
fetal pancreatic cells into athymic diabetic mice leads to normo-glycemia [29] and the use
of fibrin may assist in graft survival and function [25, 30]. Therefore, the objective of this
study is to analyze whether fibrin can promote human fetal pancreas differentiation and
proliferation in vitro and in vivo as well as the potential mechanisms involved. We
hypothesize that fibrin will promote differentiation of human fetal pancreatic progenitor
cells into insulin producing cells through integrin αvβ3 receptor up-regulation,
angiogenesis stimulation and promotion of cell proliferation.
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5.2 Materials and methods
5.2.1

Human fetal islet-epithelial cell culture and fibrin gel
preparation

Human fetal pancreata (15-21 weeks of age) were collected according to protocols
approved by the Health Sciences Research Ethics Board at Western University in
accordance with guidelines of the Canadian Council on Health Sciences Research
Involving Human Subjects. After dissociation by collagenase V, islet-epithelial cell
clusters were cultured in CMRL media containing 10% fetal bovine serum (Invitrogen,
Burlington, Ontario, CAN). To initiate polymerization, thrombin (Sigma, St Louis, MO,
USA) was added to fibrinogen, as previously described [24]. The resultant solution was
quickly inserted into wells of a 24-well plate to form 0.1-0.2mm thickness gel. Human fetal
islet-epithelial cell clusters plus medium were then added on top of the fibrin gels for the
2D experimental group or TCPS for the control group. The 3D fibrin-cultured group had
human fetal islet-epithelial cell clusters added to the fibrinogen solution before
polymerization to form 0.3mm 3D scaffold. Cell clusters plated on TCPS, 2D fibrin or 3D
fibrin were cultured for 1 and 2 weeks, and then collected for analyses. For the mTOR
inhibition study, dissociated human fetal pancreatic cells were pretreated with 20ng/mL of
rapamycin (LC Laboratories, Woburn, MA, U.S.A.) for 30 min then plated on 2D fibrin
for 48 hours. Samples were collected for protein and double immunofluorescence analysis.

5.2.2

RNA extraction and real-time RT-PCR

Total RNA was extracted from 1 week fibrin-cultured human fetal islet-epithelial cell
clusters and controls using the miRNeasy kit (QAIGEN, Germantown, MD, USA). For
each reverse transcription reaction, 2 μg of DNA-free RNA was used with random
hexamers/oligo-deoxythymidine

primers

and

superscript

reverse

transcriptase

(Invitrogen). Sequences of PCR primers used for RT-PCR with expected product size are
listed in Appendix 5. A master mix of primers, water and SYBR green was made and then
added to separate tubes with each cDNA sample. Real-time RT-PCR analyses were
conducted using the CFX manager software (Bio-Rad Laboratories, Mississauga, ON,
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Canada) and CFX Connect Real-Time System (Bio-Rad Laboratories). Data were
normalized to levels of 18S rRNA subunit and relative gene expression was calculated
based on the 2ΔΔCT method as PCR signals from 2D and 3D fibrin-cultured human fetal
islet-epithelial cell clusters relative normalized to TCPS controls.

5.2.3

Scanning electron, transmission electron and
immunofluorescence microscopy

For SEM, human fetal pancreata or fibrin-cultured human fetal islet-epithelial cell clusters
were fixed with 2.5% glutaraldehyde at 4°C overnight, then dehydrated with an increasing
concentration gradient of ethanol. Samples were subjected to critical point drying and gold
coating, and then visualized by a Hitachi 3400-N Variable Pressure Scanning Electron
Microscope.
For transmission electron microscopy (TEM), human fetal pancreata were dissected, cut
into small pieces, then fixed in 2.5% glutaraldehyde in 0.1M phosphate buffer. Postfixation was done with 1% osmium tetroxide. After dehydration through a graded ethanol
series and propylene oxide treatment, samples were embedded in araldite medium and
cured at 65°C overnight. Ultra-thin sections were cut at 60nm and examined with a Philips
410 electron microscope (Philips Electron Optics, Hillsboro, OR, USA) at 60kV.
For immunofluorescence microscopy, human fetal pancreata and cultured human fetal
islet-epithelial cell clusters were collected and fixed in 4% paraformaldehyde overnight,
followed by agarose embedding and wax processing. Sections (4μm thick) were prepared
and stained with appropriate dilutions of primary antibodies listed in Appendix 4.
Fluorescent secondary antibodies were obtained from Jackson Immunoresearch
Laboratories (West Grove, PA, USA).

5.2.4

Protein extraction and western blot analysis

Fibrin-cultured and control cell protein was extracted in a Nonidet-P40 lysis buffer. Equal
amounts (15μg) of lysate protein from each experimental group was separated by either
7.5, 10 or 12% sodium dodecyl sulfate-polyacrylamide gel electrophesis and transferred to
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a nitrocellulose membrane (Bio-Rad Laboratories, Mississauga, ON, Canada). Membranes
were incubated with appropriate dilutions of primary antibodies listed in Appendix 4. The
application of appropriate horseradish peroxidase-conjugated secondary antibodies (Santa
Cruz Biotechnologies) then followed. Proteins were detected using ECL™-Plus Western
blot detection reagents (Perkin Elmer, Wellesley, MA, USA) and exposed using the
Versadoc Imaging System (Bio-Rad Laboratories). Densitometric quantification of bands
at subsaturation levels was performed using Quantity One software (Bio-Rad Laboratories)
and normalized to appropriate loading controls. Data are expressed as the relative
expression level of phosphorylated proteins to total protein levels or protein levels to the
loading control [11].

5.2.5

Transplantation of cultured human fetal islet-epithelial cell
clusters

Freshly isolated human fetal islet-epithelial cell clusters either mixed with fibrin or type I
rat tail collagen were injected subcutaneously. Alternatively, cell clusters cultured for 1
week in either 3D fibrin or 3D type I rat tail collagen were used for subcutaneously
transplantation. Briefly, 8 week-old male nude mice were anesthetized with isoflurane and
either empty gels or gels containing cultured human fetal islet-epithelial cell clusters were
implanted subcutaneously. Mice were sacrificed at 1 week post-transplantation, where
grafts were harvested for histological analyses.

5.2.6

Statistical analysis

Data are expressed as means ± SE using 4-5 different pancreata preparations per
experimental group, representing n = 4-5. Statistical significance was determined using
either the unpaired student's t-test or one-way ANOVA followed by post hoc Bonferroni
comparison test. Differences were considered statistically significant when p<0.05.
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5.3 Results
5.3.1

The

native

human

fetal

pancreas

contained

robust

extracellular matrix and integrin αvβ3 expression
Human fetal pancreas at 16 weeks of age, analyzed by SEM, revealed very prominent ECM
fibers (Fig. 5-1A). These fibers surround cell clusters, and are also present in between
individual cells (Fig. 5-1A). Under the TEM, ECM fibers were often perpendicular to the
cell membrane (Fig. 5-1B). The RGD-domain containing ECM protein fibronectin, was
frequently associated with insulin positive cells (Fig. 5-1C), as determined by double
immunofluorescence staining.
Due to the profound expression of fibronectin in the fetal pancreas, we investigated the
expression of one of its receptors, integrin αvβ3. Integrin αvβ3 was highly expressed in the
developing human pancreas, and co-localized with PDX-1, insulin and CK-19 (Fig. 51DEF). These findings suggest that the interactions between the ECM microenvironment
and pancreatic integrin receptors is essential for normal human fetal islet development.

5.3.2

Fibrin enhanced PDX-1 and VEGF-A expression while
promoting endocrine cell differentiation of human fetal isletepithelial cell clusters

Human fetal islet-epithelial cell clusters were cultured in 2D or 3D fibrin and TCPS for up
to 2 weeks. Smaller clusters were maintained in fibrin cultured cells when compared to
TCPS cultured group (Fig. 5-2A). Scanning electron microscopy revealed connections
between cells and fibrin gels in both 2D and 3D cultures (Fig. 5-2B). Quantitative RT-PCR
analysis of human fetal islet-epithelial cell clusters after 1 week of fibrin culture showed
significantly higher expression of PDX-1, INS and GCG in 3D culture (Fig. 5-2C). Protein
levels of PDX-1 in 2D and 3D fibrin-cultured human fetal islet-epithelial cell clusters were
significantly increased during the culture period compared to TCPS controls (Fig. 5-2D).
Fibrin-cultured human fetal islet-epithelial cell clusters also showed significantly higher
expression of VEGF-A at 2 weeks of culture (Fig. 5-2E). Double immunofluorescence
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Figure 5-1 The human fetal pancreas contains ECM fibers and expresses integrin αvβ3.
(A) Scanning electron micrographs of human fetal pancreas at 16 weeks of age. Scale bar:
50μm (left) and 10μm (middle). (B) Human fetal pancreas under the transmission electron
microscope at 16 weeks of age. Scale bar: 1μm. Double immunofluorescence staining of
human fetal pancreas at 16 weeks of age for fibronectin (green)/ insulin (red) (C) and
integrin αvβ3 (green) with PDX-1 (red) (D), insulin (red) (E) and CK19 (red) (F). Scale
bar: 50μm and nuclei are stained with DAPI (blue). ECM: extracellular matrix; Endo:
endocrine cell.
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staining revealed scattered clusters of insulin and glucagon positive cells in all culture
conditions with a slight increase in both 2D and 3D fibrin-cultured groups relative to TCPS
controls (Fig. 5-2F top). The majority of cells in all cultured groups were SOX9 and CK19
positive (Fig. 5-2F middle). Higher VEGF-A expression in fibrin-cultured human fetal
islet-epithelial cell clusters was associated with prominent CD31 positive cells and
maintenance of Ki67 positive cells compared to the TCPS controls (Fig. 5-2F lower).

5.3.3

Fibrin increased integrin αv and β3 expression in human fetalislet-epithelial cell clusters

To investigate the mechanism behind fibrin’s enhancement of islet differentiation, we
analyzed the expression of various integrin receptors. At the mRNA level, 1 week cultured
human fetal islet-epithelial cell clusters had significantly increased αv and β3 integrin
expression (Fig. 5-3A). We further confirmed this observation by western blot and found
that the protein level of integrins αv and β3 were significantly higher in human fetal isletepithelial cell clusters cultured with fibrin (Fig. 5-3BC). Expression of the most prominent
integrin, β1, was unchanged by fibrin culture (Fig. 5-3B)

5.3.4

Fibrin induced PDX-1 expression via increased phospho-focal
adhesion kinase and p70s6k activity in human fetal isletepithelial cell clusters

Downstream of integrin receptors, phosphorylated focal adhesion kinase (FAK) was
significantly up-regulated in human fetal islet-epithelial cell clusters during 2D and 3D
fibrin culture compared to controls (Fig. 5-4A). No changes were observed in pathways
further downstream the FAK pathway, including phosphorylated AKT (Fig. 5-4B) and
activated ERK1/2 (Fig. 5-4C). However, phosphorylated p70s6k, a member of the mTOR
pathway, revealed significant up-regulation in human fetal pancreatic cells cultured with
fibrin compared to controls (Fig. 5-4D).
Using the mTOR pathway inhibitor, rapamycin, to treat human fetal islet-epithelial cell
clusters cultured on 2D fibrin, a significant decrease in phosphorylated p70s6k was observed
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Figure 5-2 Fibrin improves human fetal pancreatic cell differentiation and increases VEGFA expression.
(A) Human fetal pancreatic cells cultured on tissue-culture polystyrene (TCPS), on 2D and
in 3D fibrin for 3 days. Scale bars: 100μm. (B) Scanning electron micrograms of fibrincultured human fetal pancreatic cells. Scale bars: 20μm. (C) Real time RT-PCR analysis
of PDX-1, insulin and glucagon mRNA expression in human fetal pancreatic cells cultured
for 1 week with fibrin or on TCPS. Western blot analysis of PDX-1 (D) and VEGF-A (E)
in human fetal pancreatic cells during 1 and 2 weeks of fibrin culture. (F) Representative
immunofluorescence images of human fetal pancreatic cells cultured with fibrin being
stained for insulin (red)/ glucagon (green) (top row), SOX9 (red)/ CK19 (green) (middle
row) and CD31 (red) / Ki67 (green) (bottom row) and the percentage of the positive cells.
Nuclei are stained with DAPI in blue. Scale bars: 50μm. Data are expressed as means ± SE
(n=3-5). Representative blots are shown. *p<0.05, **p<0.01 and ***p<0.001 vs. TCPS
control.
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(Fig. 5-4E). Two dimentional fibrin cultures were used because the cells were affected to
the same extent as 3D fibrin culture with respect to PDX-1 protein expression and signaling
pathway activity. Inhibition of the mTOR pathway resulted in a significant decrease in
PDX-1 expression, observed by western blot (Fig. 5-4F). Furthermore, the effects of
rapamycin treatment on fibrin-cultured human fetal islet-epithelial cell clusters caused a
reduction

in

cell

proliferation,

noted

by cyclin

D1

expression

and

Ki67

immunofluorescence (Fig. 5-4GH).

5.3.5

Subcutaneous injection of human fetal islet-epithelial cell
clusters with fibrin improved vascularization

To investigate how fibrin could be used as a vehicle to transplant cells subcutaneously,
male nude mice were injected with freshly isolated human islet-epithelial cell clusters cells
mixed with fibrin immediately before polymerization (Fig. 5-5A). Cells mixed with
collagen I (Fig. 5-5B), empty fibrin and empty type I collagen (Fig. 5-5C) were used as
controls. A fibrin-wrapped cell graft was clearly observed under the skin of the nude mice
(Fig. 5-5A left). A cell core was clear, with the presence of vasculature around the fibrinwrapped graft interface (Fig. 5-5A right). A collagen-wrapped cell graft was also present
under the skin of nude mice; however, prominent vascular development was not observed
(Fig. 5-5B). At the cellular level, fibrin- and collagen I-wrapped human fetal islet-epithelial
cell grafts after 1 week implantation in vivo had relatively similar levels of insulin and
glucagon positivity (Fig. 5-5D 1st row). Both fibrin- and collagen I-wrapped human fetal
islet-epithelial cell grafts showed higher a number of SOX9/CK19 positive cells compared
to pre-implantation samples (Fig. 5-5D 2nd row). An antibody raised against human
mitochondrial surface (HMS) protein allowed for identification of the implanted human
fetal cells. These HMS positive cells showed a high level of cell proliferation as marked
by Ki67 in both the fibrin- and collagen-wrapped groups (Fig. 5-5D 3rd row). Implanted
human cells in the fibrin-wrapped group contained a high number of CD31 positive cells
with visible host CD31 positive cells around the graft (Fig. 5-5D 4th row). The collagenwrapped group had large HMS-positive vessels with minimal small vessels (Fig. 5-5D 4th
row).
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Figure 5-3 Fibrin induces integrin αvβ3 expression in human fetal pancreatic cells.
(A) Relative mRNA expression of integrin receptors in human fetal pancreatic cells
cultured for 1 week with fibrin or on TCPS. (B) Representative western blots for β1, αv
and β3 integrin expression. Quantitative analysis of integrins αv (C) and β3 (D) in human
fetal pancreatic cells during the culture period. Data are expressed at means ± SE (n=3-5).
*p<0.05, **p<0.01 and ***p<0.001 vs. TCPS control.
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5.3.6

Subcutaneous transplantation of cultured human fetal isletepithelial cell clusters with fibrin maintained insulin and
glucagon expression and improved vascularization

Human fetal islet-epithelial cell clusters were cultured in 3D fibrin or 3D collagen for 1
week, then transplanted subcutaneously into nude mice to investigate the potential of either
ECM protein to promote differentiation and vascular formation. As controls, empty fibrin
and empty collagen were cultured and transplanted adjacently. Grossly, transplantation of
fibrin-cultured cells led to a graft with vessels surrounding it, while an empty fibrin graft
can be observed immediately next to it, with markedly less vascularity (Fig. 5-6A left).
Conversely, cells cultured with collagen and then transplanted led to a graft with less
vascularity, very similar to both the empty fibrin and empty collagen grafts (Fig. 5-6A
right). Double immunofluorescence staining of insulin and glucagon was similarly
maintained in fibrin and collagen after 7 days of culture. However, after 1 week
subcutaneous transplantation, the fibrin group had slightly more insulin and glucagon
immunoreactivity than cells cultured and transplanted with collagen (Fig. 5-6B top row).
Cells cultured and transplanted with fibrin also had maintained expression of CK19, which
was lost in the collagen grafts (Fig. 5-6B 2nd row). Cell proliferation in the transplanted
groups was also maintained compared to the groups after 7 days in culture (Fig. 5-6B 3rd
row). Finally, blood vessels were prominent and elongated, similar to native pancreatic
vessels, when fibrin-cultured human fetal islet-epithelial cell clusters were transplanted
compared to the collagen group (Fig. 5-6B 4th row).

5.4 Discussion
This study investigated how fibrin can promote differentiation and proliferation of human
fetal islet-epithelial cell clusters in vitro and in vivo. The native human fetal pancreas
contains many ECM proteins, including fibronectin that may associate with integrin αvβ3.
Culture of human fetal pancreatic cells in 2D and 3D fibrin for one week significantly
increased PDX-1, insulin and glucagon expression. This was associated with up-regulation
of integrins αv and β3, VEGFA, phosphorylated FAK and phosphorylated p70s6k. The
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Figure 5-4 PDX-1 expression is regulated by mTOR signaling pathway activity.
Quantitative analysis of phosphorylated FAK (A), AKT (B), ERK1/2 (C) and p70s6k (D) in
human fetal pancreatic cells during the culture period. Western blot analysis of
phosphorylated p70s6k (E), PDX-1 (F) and cyclin D1 (G) expression, and (H)
immunofluorescence staining of Ki67 in 2D fibrin-cultured pancreatic cells with or without
rapamycin treatment. Arrows indicate proliferating cells, scale bar: 50μm and nuclei are
stained by DAPI (blue). Data are expressed at means ± SE (n=3-5). Representative blots
are shown. *p<0.05, **p<0.01 and ***p<0.001 vs. TCPS control. p: phosphorylated; t:
total.
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reduction in p70s6k phosphorylation by rapamycin treatment led to significant decreases in
PDX-1 expression and cell proliferation. Subcutaneous injection of fibrin mixed with
human fetal islet-epithelial cell clusters into nude mice showed remarkable vascularization
compared to collagen controls. We extended these results by subcutaneously transplanting
pre-cultured human fetal islet-epithelial cell clusters with fibrin, which led to maintained
expression of insulin and glucagon, but also more pronounced vascularization in the graft
compared to collagen. This study shows that fibrin can maintain human fetal islet-epithelial
clusters and enhance vessels formation in vitro and in vivo.
Robust ECM proteins are present in the developing human pancreas along with integrin
αvβ3. Previous studies have indicated the presence of multiple integrin receptors in the
human fetal pancreas, which bind to the ECM to mediate cellular responses [14]. In
particular, integrin β1 stimulates FAK and ERK1/2 to promote human islet-epithelial cell
differentiation and survival [18]. Alongside, human islet development requires integrins
αvβ3 and αvβ5 [17] and integrin αvβ1 [16] for adhesion and migration of cells. In mice,
the ECM component laminin-1 promotes differentiation of pancreatic beta cells [31], likely
through α6 integrin [32]. Culture of beta cells in hydrogels with ECM proteins improves
survival and function [33]. However, loss of beta cell phenotype including diminished
insulin expression occurs during long-term culture [34, 35]. In current study, fibrin culture
of human islet-epithelial cells replaced, at least in part, the ECM lost during pancreatic
dissociation. This led to improved expression of integrin receptors, signaling molecules
and differentiation of islet cells.
The present study demonstrated that culture of human fetal islet-epithelial cell clusters with
fibrin increased the expression of integrins αv and β3 and downstream activity of FAK and
p70s6k signaling molecules. Many integrin receptors on different cell types have been
shown to bind fibrin, including integrins αvβ3 and αIIbβ3 [36]. We have recently shown
that fibrin-culture of INS-1 cells increased expression of integrins αv and β3, but not β1
[24]. These results support the notion that stimulation of integrins with ECM can promote
cellular expression and activation of downstream signaling pathways [12, 24]. At one week
of culture, no differences in signaling pathway activity changes were observed. However,
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Figure 5-5 Subcutaneous injection of human fetal pancreatic cells with fibrin improves
vasculature.
Gross demonstrations of subcutaneously injected human fetal pancreatic cells mixed with
fibrin (A) or collagen (B) in low (left) and high (right) magnification. (C) Histological
image of control empty injections of fibrin and collagen. (D) Double immunofluorescence
labeled human fetal pancreatic cells either before injection (left column) or after 1 week in
vivo with fibrin (middle column) or collagen (right column). Cells were stained with
insulin (red)/ glucagon (green) (top row), SOX9 (red)/ CK19 (green) (2nd row), Ki67 (red)/
human mitochondrial surface protein (HMS, green) (3rd row) and CD31 (red)/ HMS (green)
(4th row). Representative images are shown with DAPI staining the nuclei (blue). Black
arrows point to graft location, while white arrowheads indicate donor derived blood
vessels. Scale bars: 50μm
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there was a trend towards increasing pathway phosphorylation in the fibrin-cultured group.
A reason for this could be that, despite having significantly more integrin receptor
expression, their activation did not reach a threshold to activate enough downstream
signaling molecules to cause an effect. Yet, after one week of fibrin culture, the expression
of insulin, glucagon and PDX-1 was increased, suggesting that these markers were being
modulated by molecules other than integrins, AKT and ERK1/2.
Aberrant mTOR pathway signaling occurs in multiple diseases states [37]. We observed
significant increases in phosphorylated p70s6k when human fetal pancreatic cells were
cultured with fibrin, which was AKT-independent (Fig. 5-4). Despite many studies
confirming that the mTOR pathway relies upon AKT, research in a pancreatic beta cell line
(INS-1) showed that beta cell proliferation mediated by active mTOR/p70s6k signaling is
AKT-independent [38, 39]. We expand on these results, suggesting that mTOR activity
was stimulated without active AKT to modulate differentiation of human fetal pancreatic
ells. However, leucine stimulation of the mTOR pathway in fetal rat pancreatic cells led to
inefficient differentiation of Pdx-1 positive cells into neurogenin-3 positive cells [40]. This
finding suggests that mTOR activity has a negative effect on pancreatic differentiation. The
major difference between our study and previous research is the use of human cells.
Numerous articles have outlined signaling pathway differences between the rodent and
human pancreas [41-43]. Also, the mTOR pathway has different effects on islet cell cycle
depending on animal species [44, 45]. In particular, stimulation of rodent islets with
palmitate led to increased DNA synthesis (in an mTOR-dependent manner) in rodent islets,
but not those isolated from humans [45]. Therefore, mTOR pathway activity may have
different effects on islet cell differentiation based on whether cells are human or rodent.
Our results suggest that the mTOR pathway has a positive effect on differentiation and
proliferation of human fetal pancreatic cells when these cells were cultured with fibrin.
When human fetal islet-epithelial cell clusters were cultured with fibrin, we observed
significant increases in VEGF-A expression (Fig. 5-2). We also observed robust vascular
presence when cells were transplanted with fibrin. Two transplantation methods are used
in the current study: (1) transplantation of human fetal islet-epithelial cell clusters with
fibrin just after polymerization initiation and (2) one week culture of cells in fibrin then
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Figure 5-6 Subcutaneous transplantation of fibrin-cultured human fetal pancreatic cells
maintains expression of insulin, glucagon, CK19 and improves vasculature.
(A) Human fetal pancreatic cells cultured for 1 week with fibrin (left) or collagen (right)
then transplanted subcutaneously into nude mice with an empty gel for 1 week. E represents
the empty gel, while G is the graft. (B) Double immunofluorescence staining of human
fetal pancreatic cells after 1 week of 3D culture with fibrin (left column) or collagen (2nd
column); or after 1 week culture and 1 week post-transplantation in nude mice (fibrin – 3rd
column, collagen – 4th column). Cells were stained for insulin (red)/ glucagon (green) (top
row), SOX9 (red)/ CK19 (green) (2nd column), Ki67 (red)/ HMS (green) (3rd column) and
CD31 (red)/ HMS (green). Representative images are shown with DAPI staining the nuclei
in blue. Scale bars: 50μm.
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transplantation of the combination subcutaneously for one week. Both of these experiments
demonstrated that transplanted fibrin-wrapped human fetal islet-epithelial cell clusters
could promote vasculature formation and maintain cell differentiation and proliferation.
Previous reports indicate that culturing human adult islets in fibrin for one week followed
by transplantation of the cells resulted in improved graft size, reduced ductal structures and
significantly increased c-peptide levels compared to animals that received free-floating
cultured islets [25]. It was postulated that the angiogenic-promoting effects of fibrin are
what led to such results. These effects have also been observed when a fibrin hydrogelislet composite was subcutaneously transplanted in mice [46]. Fetal porcine islet-like cell
clusters were transplanted under the kidney capsule of nude mice and sufficient
angiogenesis occurred to develop an autonomous microcirculation supporting these isletlike clusters [47]. Likewise, normalization of glycemia occurred when fibrin-encapsulated
VEGF-treated rat islets were transplanted into diabetic mice [48]. Results from these
studies in combination with our own confirm that blood vessel formation is important for
the maintenance of islet graft function and survival.
Fibrin has been used in many tissue-engineering specialties as a carrier [49, 50]; however,
as an encapsulation vehicle for islet transplantation, fibrin has not been well characterized.
Encapsulating rat islets with fibrin, then transplanting them into diabetic nude mice
normalized glycemia with a minimum of only 100 islet equivalents [51]. Another study
found that transplantation of islets in a fibrin glue reduced diabetic mouse blood glucose
to normal levels [30]. Our results show that human fetal pancreatic cells can be cultured
with fibrin and transplanted to yield a successful graft. Taken together, fibrin may be used
as a microencapsulation scaffold for islet transplantation to enhance outcomes.

5.5 Conclusions
The human fetal pancreas contains rich ECM fibers and expression of integrin αvβ3. Fibrin
improves human fetal pancreatic cell differentiation via the mTOR pathway that is
associated with increases in integrin αvβ3 expression. Fibrin also improves graft
vascularization when human fetal pancreatic cells are transplanted subcutaneously with or
without a pre-culture period. Understanding how fibrin promotes human pancreatic
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progenitor differentiation will enhance existing protocols that aim to generate functional
beta cells for the treatment of diabetes.
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6

General discussion, limitations and future direction
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6.1 Summary of discussion
Integrin-ECM interactions mediate a variety of cellular processes in the pancreas. The goal
of this thesis was to investigate the role of β1 integrin in the adult murine pancreas and the
role of fibrin-integrin interactions in support of pancreatic cell function, proliferation,
survival and maturation.
My first and second objectives were to investigate the in vivo role of β1 integrin on the
murine pancreas. Primary loss of β1 integrin on pancreatic stellate and beta cells had a
detrimental effect on ECM expression and tissue architecture. As well, a decrease in
pancreatic β1 integrin expression occurred, which was associated with glucose intolerance,
significantly reduced protein levels associated with exocrine tissue function and decreased
FAK/MAPK/ERK1/2 signaling pathway activity. Importantly, loss of β1 integrin led to
significantly decreased pancreatic cell proliferation and increased cell death.
The significance of this work lies in the clinical relevance for cell-based therapies for
diabetes treatments. As mentioned previously, islet transplantation requires isolation of
islets from the donor pancreas. The process of islet isolation destroys connections between
the ECM and integrin receptors, which I have shown to be essential for pancreatic cell
integrity. In particular, the loss of islet cell-cell and islet cell-endothelial cell, and islet cellbasement membrane connections leads to progressive loss of insulin expression and
increased cell death [1, 2]. The combination of these consequences leads to low quality
islets for transplantation and increases the susceptibility of graft failure. To avoid this,
transplanting islets immediately after isolation is ideal in order to re-establish islet cell
contacts with surrounding cells or ECM. However, this removes all opportunities to expand
beta cells in vitro, which has been met with limited success due to the high incidence of
cell death. For this reason, researchers have been culturing islets with various stimulating
factors or ECM proteins in an attempt to improve in vitro islet health and expand beta cells.
My third and fourth objectives were to investigate the role of fibrin-integrin interactions in
support of pancreatic cell function, proliferation, survival and maturation. Culturing INS1 cells with fibrin significantly increased integrin αvβ3 expression, improved GSIS, and
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prevented cell death through integrin αvβ3. Meanwhile, when human fetal pancreatic cells
were cultured with fibrin, significant increases in islet gene expression occurred, including
increased expression of integrin αvβ3, phosphorylated FAK and phosphorylated p70s6k.
Subcutaneous injection of human fetal pancreatic cells wrapped in fibrin led to robust
vascularization compared to collagen.
Previous studies have cultured pancreatic islets in a variety of other ECM matrix proteins,
in an attempt to recapitulate the native pancreas environment. However, culturing islets in
these conditions leads to either cystic formation [3], transdifferentiation [4], or loss of
function [5]. It appears that without stimulation of a variety of cell surface receptors, islets
are doomed to a less-than-ideal fate. Indeed, when islets are cultured with multiple ECM
proteins or matrigel (a gel derived from tumor cells), islet cells have improved insulin
secretion [6, 7]. Therefore, ensuring stimulation of cell surface receptors after islet
isolation, especially integrins, is critical to maintain or expand beta cells in vitro. Fibrin
was able to support mature beta cells with respect to function, proliferation, and survival.
There were also improvements to pancreatic progenitor differentiation when human fetal
islet-epithelial clusters were cultured with fibrin. These effects were, in part, mediated by
fibrin’s binding to integrin receptors. However, to obtain ideal maintenance of islet cell
health, it is likely that a combination of factors and ECM proteins are required during
culture.
When pancreatic cells were cultured with fibrin, integrin αvβ3 was increased with no
change in other integrin receptor expression, such as β1. It has been previously mentioned
that fibrin contains RGD domains that preferentially bind to integrin αvβ3. However, the
mechanism by which integrins mediate their own specific expression is not clear. Cells are
able to make their own ECM matrix, which may autostimulate receptors for continued
survival [8]. This feedforward mechanism may stimulate integrin receptor expression,
noted in fibroblasts [9, 10]. This, however, does not explain why only certain integrin
receptors had increased expression and others did not.
The non-receptor tyrosine kinase, FAK, had significantly decreased activity in mice
lacking β1 integrin, and significantly increased activity in pancreatic cells cultured with
145

fibrin suggesting that FAK is a mediator of integrin activation. Indeed, mice lacking beta
cell-expression of FAK had reduced viability and function due to FAK signaling pathway
down-regulation and impaired cytoskeletal dynamics [11]. The level of FAK
phosphorylation is correlated to beta cell survival, due to either cyclin-dependent kinase 5
activation [12] or after ECM culture [13]. In this way, the deleterious effects of β1 integrin
loss and beneficial effects of fibrin culture may be mediated through FAK activation.

6.2 Limitations
Common to all basic science research are the limitations associated with the use of animal
models as surrogates for humans. Rodents are the primary animal used in the studies
presented here and despite sharing a large percent of their DNA with humans, significant
differences exist. Above all, the organization of pancreatic islets differ, with significantly
more alpha cells being in contact with beta cells in humans compared to mice [14]. As well,
the glucose-induced electrical activity and insulin release of beta cells is significantly
different between mice and humans [15]. These differences should be considered when
translating these studies to humans.
One limitation of the conclusions drawn from Chapter 2 and 3 is that the promoter used to
control Cre recombinase expression has activity in multiple cell types. The β1 integrin
knockout mouse model used here has Cre expression restricted to cells that express
collagen 12. Staining for β-galactosidase showed immunoreactivity in islets and stellate
cells, with an eventual loss of β1 integrin in most of the pancreas. Despite this latency,
mice lacking β1 integrin developed significant blood glucose dysregulation associated with
decreased beta cell mass, improper insulin secretion, and reduced FAK/MAPK/ERK1/2
signaling pathway activity. A recently published study demonstrated that beta cell specific
knockout of β1 integrin using the rat insulin promoter showed significantly reduced beta
cell mass [16]. This suggests that the lack of specificity of Cre expression, in our mouse
model, did not dramatically affect the islet phenotype observed here. However, since β1
integrin loss in the current study was not specific to beta cells, secondary effects that might
explain the findings presented here cannot be ruled out.
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The main limitation of Chapter 4 is the use of the INS-1 cell line as a surrogate for primary
adult beta cells. This cell line is derived from rat insulinoma cells and has been
immortalized. It is reminiscent of normal beta cells with respect to propensity to form
clusters, secrete insulin in response to glucose, and express the majority of beta cellassociated transcription factors. However, it has significant genetic alterations that render
it categorically different than primary beta cells isolated from mice and especially humans.
Finally, two important limitations must be considered for Chapter 5. The first is the use of
human samples, which have dramatic diversity between individuals. Inbred mice have
minimal inherent differences because they are nearly genetically identical, whereas tissue
obtained from different humans have a wide range of gene expression and DNA
composition. This causes each human biological replicate to behave differently to stimuli.
In the laboratory, this leads to data that is largely insignificant unless a biological replicate
number is high enough. Another limitation of our studies using human fetal pancreatic
tissue is the timing of sample acquisition. We restricted our studies to the 15-21 week old
fetal pancreas, but may have observed more profound effects if we restricted our time point
to only a single week, or used one later in development. Unfortunately, there is a significant
lack of human fetal pancreata for research purposes, which leads to skewed data.

6.3 Future direction
The studies associated with this thesis do not present an entire story. The field of islet
biology with respect to cell adhesion receptors has much to be discovered in order to
improve upon current islet transplantation techniques.
To improve upon the first study presented in Chapter 2, future experiments should use mice
with an inducible Cre-loxP system where the β1 integrin gene is floxed and Cre expression
is restricted to beta cells of the pancreas. Mice are commercially available that have
tamoxifen-inducible Cre expression regulated by the mouse insulin promoter. Crossing this
mouse with the floxed β1 integrin mouse would yield mice that only lose β1 integrin
expression in beta cells after tamoxifen injection. This prevents any confounding factors
and better elucidates the direct role of β1 integrin in the developed endocrine pancreas.
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Alongside, it will be beneficial to isolate islets from these mice and perform in vitro GSIS
tests on them. This experiment determines the primary defect in islets and whether or not
it is due to dysfunctional insulin secretion.
Future studies for Chapter 3 of this thesis should include use of a mouse model that has
Cre expression specified to acinar cells of the exocrine pancreas. Promoters such as
amylase or carboxipeptidase-A would specify β1 integrin loss to pancreatic acinar cells,
and thus allow investigation of the direct effects of β1 integrin deficiency.
To further investigate the results of Chapter 4, the use of primary adult beta cells or islets
isolated from rodents or humans would generate more representative data. As well, it would
be of great interest to transplant fibrin-cultured adult beta cells or islets into diabetic mice,
to investigate the effects of long-term culture on the in vivo function of endocrine cells.
Finally, future studies for Chapter 5 should focus on increasing the replicate number to
ensure the data is a true representation of the human population. Alternatively, sorting cells
into various different cell populations before culture would allow for more precise data
collection since the effects of fibrin may be specific to cells expressing αvβ3. Alternatively
to cell sorting, experiments should use specific differentiation media that drive progenitor
cells towards islet-specific gene expression during fibrin culture. These effects could then
be analyzed in vivo by transplanting cells into diabetic mice.
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Appendix 4 Antibodies used for experiments
Primary antibody

Dilution

Company, Location

Mouse anti-actin

1:5000

Sigma; St. Louis, MO, U.S.A.

Rabbit anti-AKT

1:1000

Cell Signaling; Temecula, CA, U.S.A.

Mouse anti-AKT (phospho-Ser473)

1:1000

Cell Signaling; Temecula, CA, U.S.A.

Mouse anti-amylase

1:1000

Santa Cruz; Santa Cruz, CA, U.S.A.

Mouse anti-calnexin

1:1000

BD Biosciences; Mississauga, ON, CA

Mouse anti-carboxypeptidase A

1:1000

AbD serotec; Raleigh, NC, U.S.A.

Mouse anti-caspase-3

1:1000

Cell Signaling; Temecula, CA, U.S.A.

Mouse anti-cleaved caspase-3

1:1000

Cell Signaling; Temecula, CA, U.S.A.

Mouse anti-cyclin D1

1:1000

Cell Signaling; Temecula, CA, U.S.A.

Mouse anti-cytokeratin 19

1:100

Dako; Glostrup, DEN

Rabbit anti-ERK1/2

1:1000

Cell Signaling; Temecula, CA, U.S.A.

Rabbit anti-ERK1/2 (phospho-

1:1000

Cell Signaling; Temecula, CA, U.S.A.

Rabbit anti-FAK

1:2000

Cell Signaling; Temecula, CA, U.S.A.

Rabbit anti-FAK (phospho-Tyr397)

1:2000

Abcam; Cambridge, MA, U.S.A.

Rabbit anti-β-galactosidase

1:100

Abcam; Cambridge, MA, U.S.A.

Mouse anti-GFAP

1:100

Pharmingen; Mississauga, ON, CA

Rabbit anti-glucagon

1:100

Santa Cruz; Santa Cruz, CA, U.S.A.

Mouse anti-human mitochrondrial

1:50

Millipore; Billerica, MA, U.S.A.

Guinea pig anti-insulin

1:50

Zymed; San Francisco, CA, U.S.A.

Rabbit anti-Ki67

1:200

Abcam; Cambridge, MA, U.S.A.

Mouse anti-laminin

1:50

DSHB; Iowa City, IO, U.S.A.

Mouse anti-nkx6.1

1:100

DSHB; Iowa City, IO, U.S.A.

Rabbit anti-p70s6k

1:1000

Cell Signaling; Temecula, CA, U.S.A.

Rabbit anti-p70s6k (phospho-Thr389)

1:1000

Cell Signaling; Temecula, CA, U.S.A.

Rabbit anti-pdx-1

1:1500

Dr. Christopher Wright; University of

Thr202/Tyr204)

surface protein

Vanderbilt, Nashville, TN, U.S.A.
Rabbit anti-PECAM-1

1:100
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Santa Cruz; Santa Cruz, CA, U.S.A.

Mouse anti-reg-II

1:1000

R&D System; Minneapolis, MN, U.S.A.

Rabbit anti-SOX9

1:50

Abcam; Cambridge, MA, U.S.A.

Rabbit anti-αv integrin

1:1000

Abcam; Cambridge, MA, U.S.A.

Rabbit anti-β3 integrin

1:1000

Abcam; Cambridge, MA, U.S.A.

Rabbit anti-β1 integrin

1:1000

Millipore; Billerica, MA, U.S.A.

Goat anti-β1 integrin

1:150

R&D Systems; Minneapolis, MN, U.S.A.

155

Appendix 5 Primers used for experiments
Primer Name Accession &

Primer Sequence

Size (bp)

F: 5’- CAA GTG GAG GTA TCG AGA AC -3’

149

Definition
Amy1

NM_007446.2

R: 5’- CCC TGC TAC GCC AAT GTC AA -3'
Col1a1

NM_007742.3

F: 5’- CCT CCC AGT GGC GGT TAT GAC -3’

383

R: 5’- GGG TTC GGG CTG ATG TAC CAG -3’
Col1a2

NM_007743.2

F: 5’- AGG GTG AAA CTG GTC TCC GA -3’

373

R: 5’- CCC TCC ATC ACC ACG ACT TC -3’
Fn1

NM_101233.1

F: 5’- AAC TAC GAT GCC GAT CAG AA -3’

263

R: 5’- CCC TCC TCG TGA CGC TGG TG -3’
GLUCAGON

NM_002054.2

F: 5’- GAT GAA CGA GGA CAA GCG CC -3’

240

R: 5’- CCT TTC ACC AGC CAA GCA AT -3’
INSULIN

NM_000207.1

F: 5’- TAC CTA GTG TGC GGG GAA CG -3’

229

R: 5’- CTG CGG GCT GCG TCT AGT TG -3’
Insulin I

NM_019129.1

F: 5’- ACA CCC AAG TCC CGT CGT GA -3’

131

R: 5’- TGA TCC ACA ATG CCA CGC TT -3’
Insulin II

NM_019130.1

F: 5’- ATG GCC CTG TGG ATC CGC TT -3’

243

R: 5’- TGC CAA GGT CTG AAG GTC AC -3’
ITGA3

NM_002204.1

F: 5’- AGA TGC GGG CAG CCT TCG TG -3’

484

R; 5’- GTT TTC ATG CCA GAC TCA CC -3’
Itga3

NM_001108292.1 F: 5’- CTG CTA GTA GGG AGC CTG TCG -3’

223

R: 5’- TGT CAG CCT CCA CTG TGT AAG -3’
ITGA5

NM_002205.2

F: 5’- GGC CAG CCC TAC ATT ATC AG -3’

303

R: 5’- GGT TCA CGG CAA AGT AGT CA -3’
Itga5

NM_001108118.1 F: 5’- ACC AGA GCA AGA GCC GGA TAG -3’

288

R: 5’- GGT TCA CCG CGA AGT AGT CA -3’
Itga8

NM_001173972.1 F: 5’- CCC GTG TCT CTG GCG TTC AA -3’

162

R: 5’- GAT ATC CGG CTG GCT AGT GT -3’
ITGAV

NM_002210.2

F: 5’- GGA GCA ATT CGA CGA GCA CT -3’
R: 5’- ACT AAT GTT AGC AGG CGT GA -3’
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246

ItgaV

NM_001106549.1 F: 5’- TTA TGC CAA AGA TGA CCC ACT -3’

287

R: 5’- CGG GAC CTC CAA GAA GTA CTC -3’
ITGB1

NM_002211.2

F: 5’- AGA GAG CTG AAG ACT ATC CCA T -3’

313

R: 5’- CGC TGT TTT CCA ACA AGT TC -3’
Itgb1

NM_017022.2

F: 5’- GTT GGT CAG CAG CGC ATA TC -3’

369

R: 5’- GCC CAC TGC TGA CTT AGG AA -3’
ITGB3

NM_000212.2

F: 5’- AAG ATT GGA GAC ACG GTG AG -3’
R: 5’- AGT ACT TGC CCG TGA TCT TG -3’

Itgb3

NM_153720.1

F: 5’- TGG CAA GAT CAC CGG CAA GT -3’

120

R: 5’- CAG TCC GAG TCA CAC ACG CA -3’
Itgb5

NM_47139.2

F: 5’- TGG TGT TCA CGA CGG ACG AC -3’

148

R: 5’- AGC AAG GCA AGC GAT GGA TA -3’
Lama1

NM_008480.2

F: 5’- GGC GGT ATA ACA ACG GAA CC -3’

180

R: 5’- GCA ATC CAC CCA CGT AAA TC -3’
Lamb1

NM_010721.2

F: 5’- CGA GAG TAT GAG GCG GCA CT -3’

285

R: 5’- CAC TTC CAC CAA GCG GGT CT -3’
Lamc1

NM_010683.2

F: 5’- TAG CCA AAT TAG CCG ACT GC -3’

122

R: 5’- GCT CCC TGG AGG CGA TCT CA -3’
PDX1

NM_001108292.1 F: 5’- CTG CTA GTA GGG AGC CTG TCG -3’

223

R: 5’- TGT CAG CCT CCA CTG TGT AAG -3’
Pdx1

NM_022852.3

F: 5’- GGC TTA ACC TAA ACG CCA CA -3’

175

R: 5’- AGA GTC CCA GAG GCA GAC CT -3’
18S

NR_046237.1

F: 5’- GTA ACC CGT TGA ACC CCA TTC -3’
R: 5’- CCA TCC AAT CGG TAG TAG CG -3’
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